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1 Introduction 
 
 
1.1 PLRG-1, an evolutionary conserved component of the spliceosome 
 
 Mammalian Pleiotropic Regulator (PLRG-) 1 is an essential component 
of the spliceosome. PLRG-1 belongs to a highly conserved family of seven 
WD40 domain containing proteins in eukaryotes (Ajuh et al., 2000; Ajuh et al., 
2001). Founding members of this WD40-repeat protein family, PRL1 and PRL2, 
were first identified by T-DNA tagging in Arabidopsis thaliana (Nemeth et al., 
1998). Mutation of Arabidopsis PRL1 confers hypersensitivity to glucose, 
sucrose and several plant hormones and results in transcriptional derepression 
of glucose and stress responsive genes (Nemeth et al., 1998). Whereas in 
plants the PRL genes are uniquely duplicated, in yeast, C. elegans and 
mammals there are only single orthologues of the Pleiotropic Regulator family 
which play important roles in the control of cellular homeostasis. siRNA-
mediated knock-down of PLRG-1 (D1054.15) in C. elegans results in early 
embryonic lethality, whereas mutation of the yeast homologue YPL151c (Prp46) 
arrests cell proliferation causing a dual block in G1/S- and M-phase progression 
(Albers et al., 2003; Sonnichsen et al., 2005). Despite genetic studies of 
mutations, the exact regulatory function of PLRG-1 orthologues and the 
molecular mechanisms by which they integrate splicing and control cell 
proliferation so far remain elusive.  
 Human PLRG-1 has been initially identified as a subunit of spliceosomal 
complexes purified from HeLa nuclear extracts by coimmunoprecipitation with 
CDC5L (Ajuh et al., 2000). Later, it was observed that interaction between 
PLRG-1 and CDC5L is essential for pre-mRNA processing as peptides 
inhibiting complex formation of CDC5L with PLRG-1 efficiently block pre-mRNA 
splicing (Ajuh and Lamond, 2003). These studies also revealed that other 
proteins not directly implicated in regulation of pre-mRNA splicing, such as the 
cell cycle phosphatase PPM1D/WIP1, PP1-α and the DNA-dependent kinase 
(DDK)-α co-purified with the PLRG-1 containing CDC5L complex (Ajuh et al., 
2000). These components also play a role in cell cycle regulation, apoptosis 
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and genome integrity. WIP1, a serine/threonine phosphatase, is a member of 
the PP2C family and was shown to be a negative regulator of p53 (Fiscella et 
al., 1997; Lu et al., 2004; Takekawa et al., 2000). PP1-α another 
serine/threonine phosphatase, plays an important role in the control of cell cycle 
progression and apoptosis by interacting with retinoblastoma protein (Liu et al., 
1999) The other complex component, DNA-dependent kinase DDK-α, a 
serine/threonine kinase, is activated by DNA association and plays a role in 
processes such as DNA double-strand break repair, telomere maintenance and 
gene transcription (Boulton and Jackson, 1996; Boulton and Jackson, 1998; 
Smith and Jackson, 1999; Taccioli et al., 1998). 
 Recently, the CDC5L-PLRG-1 complex was demonstrated to interact 
with the WRN protein, which is deficient in Werner syndrome and required for 
processing of DNA interstrand crosslinks (Zhang et al., 2005). In addition to pre-
mRNA splicing, the CDC5L-PLRG-1 complex is thus possibly involved in DNA 
repair. Another known component of the nuclear CDC5L-PLRG-1 complex is 
the mammalian homologue Pso4/PRP19, which is essential both for pre-mRNA-
splicing and UV-radiation mediated crosslink repair (Mahajan and Mitchell, 
2003). These findings strongly suggest that the Pso4-CDC5L-PLRG-1 complex 
integrates pre-mRNA splicing and DNA-repair. 
 
 
1.2 Regulation of pre-mRNA splicing 
 
 Most genes in eukaryotes are interrupted several times by intervening 
sequences, known as introns, which are transcribed into primary messenger 
RNA transcripts (pre-mRNA). For functional translation, these non-coding 
sequences have to be precisely excised, generating functional mRNAs. This 
task is performed by a ribonucleoprotein complex, called spliceosome. This 
complex consists of five small nuclear ribonuclearprotein (SnRNP) complexes 
U1, U2, U4, U5 and U6 and about 300 other non-snRNP proteins (Rappsilber et 
al., 2002; Zhou et al., 2002). The spliceosome orchestrates the precise excision 
of introns by several RNA-RNA, RNA-protein and protein-protein interactions. A 
key feature of correct splicing is the presence of a conserved 5´ and 3´ splice 
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site, a branch point region usually 20-40 nucleotides upstream of the 3´ splice 
site and a polypyrimidine tract in the intron (Reed 1989; Smith et al., 1989; 
Stephens and Schneider 1992). 
 For many years it was thought that the spliceosome assembles in a 
stepwise manner. First, U1 snRNP binds to the 5´ splice site, while the 
serine/arginine (SR) protein U2AF65 binds the polypyrimidine tract and another 
SR protein U2AF35 binds the 3´ splice site (Merendino et al., 1999; Wu et al., 
1999; Zamore et al., 1992; Zorio and Blumenthal, 1999). This RNA-protein 
complex is known as the E-complex (Michaud and Reed, 1991). Then, U2 
snRNP binds weakly to the pre-mRNA using the integral associated U2 snRNP 
protein SF3b (Hastings and Krainer, 2001). Next, U2 snRNP binds to the 
branchpoint region forming the A-complex, a process dependent on ATP 
(Furmen and Glitz, 1995; Kramer, 1996). Subsequently, the U4/U6.U5 tri-
snRNP complex adheres to the 5´ splice site by interacting with Prp8 and the 
pre-mRNA in the presence of ATP, thereby generating the B-complex (Brown 
and Beggs, 1992; Umen and Guthrie, 1995; Umen and Guthrie, 1995). 
Exclusion of U1 and U4 snRNP leads to the active C-complex, which catalyzes 
the excision of introns (Fig. 1.1) (Jurica et al., 2004; Yean and Liu, 1991). 
 Recent findings suggest, that the spliceosome is partly preassembled 
(Nilsen 2002; Stevens et al., 2003). Upon complete assembly, the spliceosome 
undergoes dramatic conformational changes involving both its RNA and 
proteins prior to catalysis. These rearrangements result in the exclusion of two 
snRNPs, U1 and U4, and inclusion of new proteins, responsible for correct 
splicing reactions (Makarov et al., 2002; Staley and Guthrie, 1998) leading to 
the active complex. 
 The splicing reaction occurs in two steps by transesterification. First, the 
2´OH group of the branchpoint adenosine performs a nucleophilic attack at the 
5´ splice site, destroying the phosphodiesterbond and thereby generating a 
2´5´phosphodiester link (lariat structure in intron) between the adenosine of the 
branchpoint sequence and the 5´ terminal intronic nucleotide. Second, the free 
3´OH group of the 5´ exon performs a nucleophilic attack at the 3´ splice 
junction, thereby generating a new phosphodiesterbond between the 5´ and 3´ 
exon resulting in excision of the intronic sequence (Pasman and Garcia-Blanco, 
2001). 
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 PLRG-1 and CDC5L have both been shown to be involved in splicing 
reactions. These nuclear proteins are components of a large complex 
containing other splicing factors (Ajuh et al., 2000; Burns et al., 1999; Chen et 
al., 1999; McDonald et al., 1999; Neubauer et al., 1998). This conserved 
subspliceosomal complex is known as NTC (nineteen complex) in yeast and 
Prp19/CDC5L complex (Pso4-complex) in mammals (Ajuh et al., 2000; 
Makarova et al., 2002). Depletion of this complex leads to a block in splicing 
before the first transesterfication step in splicing and lariat formation of the pre-
mRNA (Makarova et al., 2002). 
Although it was shown that both proteins are essential for splicing per se 
(Ajuh et al., 2001), mutation of CDC5L in yeast yielded in a G2/M block in part 
due to incorrect splicing of TUB1 α-tubulin gene (Burns et al., 2002). Mutation of 
Prp46p (PLRG-1 in mammals) in yeast also results in a G2/M block (Albers et 
al., 2003). These findings indicate that not only splicing factors are required for 
correct pre-mRNA splicing, but in addition they play an important role in cell 
cycle regulation.  
Recent findings showed that the SR protein SF2/ASF is a proto-
oncogene. Overexpression of SF2/ASF in vitro resulted in immortal rodent 
fibroblasts. In addition, SF2/ASF is upregulated in many tumors and knockdown 
of this SR protein inhibits tumor growth (Karni et al., 2007). Furthermore, it was 
shown that nuclear protein phosphatases, such as PP2Cγ, PP1, PP2A or WIP1, 
are components in spliceosomal assembly and catalysis (Fig 1.1) (Moorhead et 
al., 2007). These proteins also play functional roles in chromosome 
condensation (Trinkle-Mulcahy and Lamond, 2006; Vagnarelli et al., 2006), 
chromatid cohesion (Kitajima et al., 2006), TGFß signalling (Duan et al., 2006; 
Knockaert et al., 2006; Lin et al., 2006) or in posttranslational control of p53 (Lu 
et al., 2005).  
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 In summary, splicing factors assembled in the spliceosome are not only 
required for correct pre-mRNA splicing. They also play important roles in other 
pathways, such as cell cycle progression, cytokine signalling or DNA damage 
response.  
 
 
 
 
A YYYYYY AGGUExon1 Exon2
A YYYYYY AGGUExon1 Exon2
U2AF65 U2AF
35U1 snRNP
A YYYYYY AGGUExon1 Exon2
U2AF65 U2AF
35U1 snRNP U2 snRNP
A YYYYYY AGGUExon1 Exon2
U2AF65 U2AF
35U1 snRNP U2 snRNP
U4 snRNP
U5 snRNP
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A YYYYYY AGGUExon1 Exon2
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E-complex
A-complex
B-complex
C-complex
Figure 1.1: Schematic 
representaion of splicing 
reaction  
Nuclear protein 
phosphatases, which are 
involved in spliceosomal 
assembly and catalysis are 
depicted next to arrows. A 
represents the adenosine 
in the branchoint region, 
YYYYYY the 
polypyrimidine tract, GU 
the 5´ splice site and AG 
the 3´ splice site. This 
scheme was composed 
based on information from: 
Hastings et al., 2001; 
Moorhead et al., 2007 
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1.3 Role of PLRG-1 in DNA repair  
 
 DNA damage is a common cellular event that, if persistant, can lead to 
mutations, cancer, cell death or even the death of an entire organism. Several 
cellular responses enable the cell to either eliminate or to cope and survive with 
the damage or to activate programmed cell death, called apoptosis. These 
cellular responses include the removal of DNA damage, through repair and 
restoration of the integrity of the genome, activation of DNA damage 
checkpoints, leading to cell cycle arrest until damage is restored, transcriptional 
responses, which change the cellular profile, and apoptosis, when damage is 
not reparable and cells are severely dysregulated.  
 The term “DNA damage” comprises genome mutations, as for example in 
Down syndrome, and chromosomal mutations, such as translocation, deletion, 
insertion and inversion. Gene mutations are generated spontaneously or by 
external influences, such as ultraviolet (UV) radiation, inducing reactive oxygen 
species or leading to DNA base damages, here pyrimidine dimers or 
photoadducts. Other DNA damages are DNA backbone damages, including 
abasic sites and DNA single- and double-strand breaks. Abasic sites can 
develop spontaneously, due to base excision repair or formation of unstable 
base adducts (Memisoglu and Samson, 1998; Mol et al., 1999; Wilson, 1998). 
DNA single-strand breaks are caused by DNA damaging agents or as 
intermediates in nucleotide excision repair (Sancar 1996; Wood, 1997). DNA 
double-strand breaks are natural intermediates in recombination, but can also 
be generated by damaging agents, like ionizing radiation (Bonura et al., 1993; 
Natarajan et al., 1993; Priebe et al., 1994). Other agents, like mytomycin C or 
cisplatin, lead to interstrand or protein-DNA crosslinks (Jones and Yeung, 1990; 
Matsumoto et al., 1989; Stevnsner et al., 1993). 
 The cell relies on various DNA repair mechanisms that are activated in 
response to DNA damage, including direct repair, base excision repair, 
nucleotide excision repair, DNA double-strand break repair and repair of 
interstrand crosslinks.  
 Direct repair reverses photoadducts resulting from UV-irridation by 
photolyases or O6-alkyl guanine appearance in DNA by transfer of the alkyl 
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group from the DNA to a cysteine in O6-alkylguanine-DNA alkyltransferase 
(Baer and Sancar, 1989; Gerson et al., 1987). 
 Base excision repair removes a damaged base by generating an apurin 
or apyrimidine (AP) site and subsequently filling the gap with an undamaged 
base. Alternatively, a long-patch pathway is used, where a complex consisting 
of RFC/PCNA-Pol δ/ε enables repair synthesis and nick translation, displacing 
several nucleotides (Frosina et al., 1996). The flap structure is then cleaved and 
the long-patch repair is ligated. Nucleotide excision repair is the major pathway 
for removing bulky adducts and uses a multiprotein complex to resolve DNA 
damage (Aboussekhra et al., 1995; Evans et al., 1997). 
 DNA double-strand breaks are repaired either by homologous 
recombination or nonhomologous end-joining (Takata et al., 1998). The 
advantage of homologous recombination is the full restoration of the lesion, 
without losing information, except in cases where the two duplexes are not 
exactly homologous and gene conversion may take place.  
 Nonhomologous end-joining is essential for V(D)J recombination and is 
thought to be the major pathway for DNA double-strand break repair induced by 
ionizing radiation (DiBiase et al., 2000; Grawunder et al., 1998; Wang et al., 
2001). Crosslinks induce DNA double-strand breaks during replication both in 
vivo and in vitro, presumably due to replication fork collapse and nuclease 
attack (Bessho, 2003; McHugh et al., 2000; Rothfuss and Grompe, 2004). The 
major error free pathway involves incision of the crosslinked DNA by the 
nucleotide excision repair enzymes, followed by gap filling via recombination 
and involvement of RecA protein (Cole, 1973; Sladek et al., 1989). Another 
error-prone pathway involved in ICL repair, consists of the NER pathway, 
subsequently followed by DNA polymerase II-dependent DNA synthesis 
(Berardini et al., 1999; Jachymczyk et al., 1981).  
 The mismatch repair factor mutSβ recognizes the ICL by stimulation of 
PCNA. Subsequently, the WRN protein, RPA and the Pso4-complex are 
recruited to the point of DNA damage by an unknown mechanism (Zhang et al., 
2005). This complex then unwinds the double-stranded DNA, forming single 
strands near to the interstrand crosslink. The unwound DNA represents a 
landmark for asymmetrical incisions that release the interstrand crosslink from 
one strand leading to a gap in the DNA. The heterodimer of the Ercc1 and Xpf 
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endonucleases produces the incision on both sides of the ICL (Kuraoka et al., 
2000). The resulting gap is repaired by either translesion bypass or homologous 
recombination (Berardini et al., 1997; Berardini et al., 1999 McHugh et al., 
2000;) (Fig. 1.2). The gap filling takes place in the following S-phase, where 
homologous recombination occurs, showing that replication and cell cycle 
progression are crucial for repairing ICL in mammals (Akkari et al., 2000). 
 
 
 
 
 
Figure 1.2: Schematic representation of the Pso4-complex in ICL repair 
ICL is represented by the connection of the complementary DNA strands. The Pso4 
complex consists of tetrameric Pso4, also known as Prp19, CDC5L,PLRG-1 and 
Spf27. This scheme was composed based on information from: Ohi et al., 2005 and 
Zhang et al., 2005 
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 However, until now, it is not clear, whether DNA repair proteins 
participate directly in DNA damage checkpoint responses.  
 
1.4 DNA damage leads to cell cycle arrest 
 
The G1/S, intra-S and G2/M DNA damage checkpoints are responsible for 
the delay or arrest of cell cycle progression in response to DNA damage. A 
common feature of these checkpoints is their signal transduction pathway (Fig. 
1.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 However, the functions of different components of the DNA damage 
checkpoint pathway are not rigidly defined, as for example the protein ataxia 
telengiectesia mutated (ATM) can act as a sensor and as a signal transducer 
(Sancar et al., 2004). 
DNA damage is recognized by two groups of proteins: the two 
phosphoinositide 3-kinase-like kinase (PIKK) familiy members ATM and ATM 
and Rad3 related (ATR) and the RFC/PCNA (clamp loader/polymerase clamp)-
related Rad17-RFC/9-1-1 complex. ATM and ATR are serine/threonine kinases, 
whose activation leads to phosphorylation of proteins, such as Chk1, Chk2, 
DNA damage
Sensors:
e.g. ATM,ATR
Mediators: 
e.g. BRCA1, 53BP
Transducers:
e.g. Chk1, Chk2
Effectors:
e.g. p53, Cdc25
G1 S G2 M
Figure 1.3: Schematic 
representation of DNA 
damage checkpoint 
pathway 
Components of human DNA 
checkpoint protein are 
depicted here. DNA damage 
is detected by sensors, 
which activate with or without 
the help of mediators, 
transducers and effectors. 
The effectors themselves 
inhibit cell cycle progression 
until DNA damage is 
repaired or lead to apoptosis 
(for p53). 
Adapted from Sancar et al. 
2004 
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BRCA1 or p53 (Emili, 1998; Gardner et al., 1999; Sanchez et al., 1999; Vialard 
et al., 1998; Walworth et al., 1993). ATM is activated by DNA double-strand 
breaks, whereas ATR seems to be more important for DNA damage checkpoint 
response caused by UV irridation or stalled replication forks (Guo et al., 2000; 
Liu et al., 2000; Matsuoka et al., 1998). Mediators like BRCA1 or 53 BP1 link 
the DNA damage sensors ATM, ATR with the transducers Chk1 and Chk2 
(Schultz et al., 2000; Soulier and Lowndes, 1999; Sun et al., 1998; Wang et al., 
2002). This signal cascade is required for correct DNA damage checkpoint 
response leading to a block in cell cycle transition. In mammals, DNA double-
strand breaks are sensed by ATM transducing its signal to Chk2, whereas ATR 
activates Chk1 after UV irridation (Hirao et al., 2000; Matsuoka et al., 2000; 
Zhao and Piwnica-Worms, 2001). ATM and ATR phosphorylate p53 at serine 
15 leading to its stabilization and activation (Banin et al., 1998; Canman et al., 
1998; Lakin et al., 1999). Chk1 and 2 themselves phosphorylate p53 and Cdc25 
leading to a G1/S phase block (Lin et al., 1992; Mailand et al., 2000; Melchionna 
et al., 2000; Sanchez et al., 1997; Shieh et al., 2000; Zhao et al., 2002). 
Phosphorylation of Cdc25 results in binding to the 14-3-3δ protein excluding 
Cdc25 from the nucleus and targeting it for degradation by the 26S proteasome 
(Mailand et al., 2000, Peng et al., 1997). Loss of nuclear Cdc25 results in 
Cdk2/CyclinE phosphorylation by Wee1 and Myt1 kinases leading to its 
inactivation (Coulonval et al., 2003; Mailand et al., 2000). This inactive complex 
is not able to activate Cdc45, thereby inhibiting replication initiation (Costanzo et 
al., 2003) (Fig. 1.4).  
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P
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P
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The tumour suppressor p53 acts as a major player in a broad range of 
cellular stress responses. The functional signal transduction circuit of p53 
consists of upstream mediators involving DNA damage, hypoxia, nucleotide 
depletion, aberrant growth signals, and chemotherapeutic drugs (Levine, 1997), 
whereas the regulatory circuit consists of p53 itself, Mdm2, p14Arf (in mouse 
p19Arf) and E2F-1, and downstream effectors including genes responsible for 
cell cycle arrest, such as p21 (el-Diary et al., 1994), inhibition of angiogenesis 
and metastasis (Kelly-Spratt et al., 2004; Zhang et al., 2000), apoptosis and 
DNA repair (Ford et al., 1997; Miyashita et al., 1995).  
 Two regulatory loops are essential for maintaining cellular p53 levels. On 
the one hand, Mdm2 forms a feedback loop with p53, in which p53 positively 
regulates Mdm2 by activating its transcription. Mdm2, in turn, negatively 
regulates p53 by promoting p53 ubiquitination and degradation (Honda et al., 
Figure 1.4: Schematic 
representation of the G1/S 
checkpoint 
Due to DNA damage, Chk1 
and 2 are phosphorylated 
and activated, leading to 
Cdc25A and p53 
phosphorylation, 
respectively. On the one 
hand, Cdc25A 
phosphorylation leads to its 
nuclear exclusion and 
degradation, enabling the 
phosphorylation and 
inactivation of CDK2/Cyc E 
complex by Wee1 and Myt1 
kinases. As a result, Cdc45 
is not phosphorylated, 
blocking  replication 
initiation. On the other hand 
phosphorylation of p53 
stabilizes itself and 
enhances p21 expression, a 
CDK inhibitor. p21 binds and 
inhibits CDK4/Cyc D1 
complex leading to 
hypophosphorylation of 
retinoblastoma protein (Rb, 
not shown). Rb binds and 
inhibits E2F, blocking 
transcription of genes 
responsible for G1/S-phase 
progression. Adapted from 
Sancar et al. 2004 
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1997). On the other hand, E2F-1 activates p14Arf transcription, whereas p14Arf 
facilitates proteolytic degradation of E2F-1 (Mason et al., 2002). These loops 
are interconnected by p53 and p14Arf. p53 inhibits the transcription of p14Arf, 
whereas the latter p14Arf interacts with Mdm2, thereby inhibiting ubiquitination 
and degradation of p53. In turn, p53 inhibits the transcription of p14Arf.(Sancar 
et al., 2004)  
In response to DNA damage, upstream activators of p53, such as ATM, 
ATR, Chk1 and Chk2 are activated, leading to phosphorylation of p53 and/or 
Mdm2 (Banin et al., 1998; Shieh et al., 2000). Phosphorylation of these proteins 
activates p53 through three distinct mechanisms: first by stabilizing p53 by 
disrupting the binding of Mdm2 to p53; second by enhancing p53 transactivation 
activity and third by promoting p53 shuttling into the nucleus (Jabbur et al., 
2000; Sakaguchi et al., 1997; Unger et al., 1999; Zhang and Xions, 2001). 
Activated p53 itself activates or represses target genes (e.g. Mdm2) or interacts 
with other coactivator or  transcrition factors, such as CBP and Ets1, thereby 
activating or repressing the transcription of target genes (Alarcon et al., 1999; 
Lambert et al., 1998; Xu et al., 2002). In addition, p53 promotes apoptosis by 
activating pro-apoptotic genes, such as Bax, Bad or Apaf-1 (Jiang et al., 2006; 
Miyishtia et al., 1994; Moroni et al., 2001).  
 Another target of p53 is the serine/threonine phosphatase WIP1, which 
dephosphorylates and destabilizes p53 (Lu et al., 2005). WIP1 was found to 
attenuate UV-induced phosphorylation of p53 at Ser 46 by inactivating 
p38MAPK and thereby inhibiting apoptosis (Takekawa et al., 2000). 
Interestingly, over-expression of WIP1 is found in many tumours, including 
breast cancer (Bernards, 2004).  
 The intra-S-phase checkpoint is activated by DNA damage or stalled 
replication machinery occurring in the S-phase leading to a block in DNA 
replication. This checkpoint requires a large set of checkpoint proteins, such as 
ATM, the M/R/N complex, MDC1 and BRCA1 (Howlett et al., 2002; Mirzoeva 
and Petrini, 2001; Scully et al., 1997; Stewart et al., 2003). Due to spontaneous 
occurrence of DNA double-strand breaks, ATM, ATR and DNA-PK 
phosphorylate the histone variant H2AX at serine residue 139 (Burma et al., 
2001; Park et al., 2003; Ward and Chen, 2001). The phosphorylated H2AX, 
called γ-H2AX, binds to MDC1, thereby establishing a large zone of modified 
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chromatin surrounding the DNA double-strand break (Goldberg et al., 2003). 
The interaction of both proteins enables the recruitment of other factors, such 
as Nbs1, Rad51 or BRCA1 to the DNA lesion leading to DNA damage repair 
(Lou et al., 2003; Stewart et al., 2003). These supramolecular structures at DNA 
double-strand breaks are termed ´foci´. 
Similar to the G1/S checkpoint, an ATM-regulated pathway is responsible 
for Cdc25A regulation (Xiao et al., 2003). A second pathway depends on the 
phosphorylation of SMC1 by ATM resulting in DNA synthesis inhibition (Kim et 
al., 2002; Yazdi et al., 2002).  
 Activation of the G2/M checkpoint prevents cells progressing into mitosis, 
a process triggered by p53-mediated regulation of the Cyclin-dependent kinase 
Cdc2 (Winters et al., 1998). Cdc2 is activated through phosphorylation at 
threonine 161 by the CDK-activating kinase (CAK) and is bound to Cyclin B (Gu 
et al., 1992; Larochelle et al., 2007). During the G2 phase, the Cdc2/Cyclin B 
complex is inactive when Cdc2 is phosphorylated on tyrosine 15 and threonine 
14 by the protein kinases Wee1 and Myt1, respectively (Den Haese et al., 1995; 
Fattaey and Booker, 1997; Mueller et al., 1995). At the transition of G2 into M 
phase, the phosphatase Cdc25 dephosphorylates Cdc2 (Lammer et al., 1998). 
In turn, the Cdc2/Cyclin B complex phosphorylates and further activates Cdc25, 
initiating a positive feedback loop (Hoffmann et al., 1993; Margolis et al., 2006). 
Activated Cdc2/Cyclin B complex leads to progression into mitosis (Li et al., 
1997). p53 binds and inhibits CAK in vitro, thereby preventing the activation of 
Cdc2 at threonine 161 (Schneider et al., 1998).  
The CDK inhibitor p21 inhibits CDK activity by binding directly to 
CDK/Cyclin complexes leading to a G2/M arrest (Dulic et al., 1998; Medema et 
al., 1998). Also, it interferes with the activating phosphorylation of Cdc2 by CAK, 
thus preventing phosphorylation at threonine 161 (Mandal et al., 1998). Another 
mechanism involving CDK2-mediated Cdc2 inhibition was shown in Xenopus. 
There, p21 inhibits CDK2 causing loss of Cdc2 activity (Guadagno and 
Newport, 1996). 
Additionally, the p53 target gene Gadd45 is able to dissociate the 
Cdc2/Cyclin B1 complex by binding to Cdc2 with its N-terminal part (Zhan et al., 
1999). 
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Another mechanism for the G2/M arrest is the regulation of the 
subcellular localization of Cdc2. The p53 target gene 14-3-3δ is responsible for 
nuclear exclusion of Cdc2 (Chan et al., 1999). It binds directly to the 
Cdc2/Cyclin B1 complex and sequesters it to the cytoplasm.  
Furthermore, p53 induces transcription of target genes, such as reprimo 
(Ohki et al., 2000), B99 (Utrera et al., 1998) and MCG10 (Zhu and Chen 2000). 
All three proteins contribute to an arrest of cells in G2 phase, but the precise 
mechanisms of the specific cell cycle arrest are still unknown.  
Repression of topoisomerase II is another mechanism for the G2/M arrest 
by p53 (Sandri et al., 1996; Wang et al., 1997). During the G2/M transition, 
topoisomerase II is responsible for creating higher order compaction of 
chromatin and inhibition blocks cells in G2/M progression (Anderson and 
Roberge, 1996). 
 When cell cycle progression is impaired due to unreparable DNA 
damage, the cell induces programmed cell death. 
 
 
1.5 Regulation of apoptosis in DNA damage and repair 
 
 Programmed cell death, called apoptosis, is a crucial and conserved 
pathway in multicellular organisms (Kerr et al., 1972). The genetically 
programmed cell death ensures the proper elimination of dysregulated cells and 
maintains tissue homeostasis. Important roles for apoptosis in many diseases 
have been revealed in recent years. Lack of apoptosis may result in cancer, 
while excessive cell death leads to neurodegeneration (Landesman-Bollag et 
al., 1998; Zuscik et al., 2000). In contrast to necrosis, apoptosis requires 
energy, concerted action of a cascade of genes and does not lead to 
inflammation (Fadok et al., 1992; Shiraishi et al., 2001; Slee et al., 1999). 
Apoptotic cells shrink and condense, the cytoskeleton collapses, the nuclear 
envelope dissambles and the DNA is fragmented. Furthermore, apoptotic cells 
are characterized by cell membrane bledding and phosphatidylserine exposure 
allowing macrophages to phagocytose them (Fadok et al., 1992). 
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  The tight control of this pathway is essential for every metazoan, 
because dysregulated apoptosis results in the death of the organism. In 
mammalian cells, apoptosis is mediated by extrinsic (death-receptor-mediated) 
and intrinsic (mitochondria-mediated) signaling pathways (Du et al., 2000; Li et 
al., 2001; Liu et al., 1996; Scaffidi et al., 1998; Susin et al., 1999; Verhagen et 
al., 2000). However, damage or stress in many organelles such as nucleus or 
ER (besides mitochondria) may trigger apoptosis (Kaufman et al., 1999; Li et 
al., 2006; Patil and Walter, 2001; Rich et al., 2000; Zhou et al., 2001). These 
pathways converge onto a family of proteases, the caspases. Activation of 
caspase-family proteases is at the core of apoptotic cell death, representing a 
common point of intersection (Nunez et al., 1998). Common to these proteases 
is their expression as zymogens that possess a cysteine in their active site, 
which is responsible for cleaving their substrates after aspartate residues 
(Alnemri 1997). Caspases that participate in apoptosis can be divided into two 
major classes, the upstream `initiator` caspases group, consisting of caspases 
2, 8, 9, 10 and 12 and the downstream `executor` caspases group including 
caspases 3, 6 and 7. Caspases collaborate in proteolytic cascades, whereas 
the activation of the caspases is dependent on the ability of certain procaspases 
to oligomerize and autoactivate themselves (Srinivasula et al., 1998; Van de 
Craen et al., 1999).  
Procaspases either assemble at the plasma membrane (caspase 8) or 
reside in aggregates in the cytoplasm (caspase 9) (Fan et al., 2005). In the first 
case, binding of either FasL or TNFα to their respective `death` receptors leads 
to recruitment of procaspase 8 (initiator caspase) in the vicinity of the receptor 
through interaction with the adaptor molecule Fas-associated death domain 
(FADD). This results in formation of a `death-inducing signal complex` (DISC) 
and results in the dimerization and autoactivation of procaspase 8 (Kischkel et 
al., 1995; Medema et al., 1997). In turn, the active caspase 8 leads to activation 
of executor caspases such as caspase 3 (Woo et al., 1998). The mitochondria-
mediated pathway for apoptosis is activated by a myriad stimuli, including 
growth factor deprivation, oxidant, DNA-damaging agents and others (Aoki et 
al., 1997; Cook et al., 1999; Lee et al., 2000; Madeo et al., 1999; Maroto and 
Perez-Polo, 1997; Sanz et al., 2000; Zhan et al., 1994; Zhan et al., 1999).  
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In the mitochondria-mediated pathway, procaspase 9 (initiator caspase) 
is recruited to a protein complex called the `apoptosome`, which consists of 
several Apaf-1 molecules. Oligomerization of Apaf-1 is induced by cytochrome 
c, that is released from the mitochondria (Srinivasula et al., 1998). The following 
recruitment of procaspase 9 leads to its activation (Srinivasula et al., 1998). 
This in turn cleaves and activates procaspase 3 (Li et al., 1997). Active caspase 
3 will cleave specific vital substrates, such as poly (ADP-ribose) polymerase 
(PARP), PAK, certain isoforms of PKC and ICAD, resulting in the complete 
destruction of the cell associated with a typical DNA degradation pattern 
(`ladder pattern`) (Frutos et al., 1999; Sakahira et al., 1998 Tewari et al., 1995; 
Walter et al., 1998) .  
Mitochondria can also participate in cell death pathways induced via 
TNF-family `death receptors`, through cross-talk mechanisms involving 
proteins, such as Bid, a pro-apoptotic member of the Bcl-2-family (Grinberg et 
al., 2005). In addition, caspase 8 cleaves and activates proteins from the Bcl-2 
family, such as Bid, which catalyzes the permeabilization of the outer 
mitochondrial membrane, thus releasing cytochrome c and thereby facilitating 
the formation of the apoptosome (Kim et al., 2000; Korsmeyer et al., 2000 Li et 
al., 1998).  
However, mitochondrial and death receptor pathway for caspase 
activation are fully capable of independent operation in most types of cells 
(Fulda et al., 2001). 
 
 
1.6 Involvement of the Bcl-2 family in the regulation of apoptosis 
 
Apoptosis and caspase activation can be modulated by members of the 
Bcl-2 family. This protein family consists of anti- and pro-apoptotic members, 
which have the ability to prevent or force cells into undergoing apoptosis, 
through the modulation of mitochondrial release of cytochrome c and other 
apoptogenic proteins from this organelle (Liu et al., 1996; Scarlett and Murphy, 
1997, Susin et al., 1999). It has been shown that the relative amounts of pro- 
and anti-apoptotic proteins determines the susceptibility of the cell to undergo 
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apoptosis (Oltvai et al., 1993; Wada et al., 1998). Members of the Bcl-2 family 
proteins are capable of physically interacting, forming homo- and heterodimers, 
and function as agonists or antagonists of each other (Gross et al., 1998; 
Mikhailov et al., 2001; Mikhailov et al., 2003). Pro-apoptotic members of the Bcl-
2 family, such as Bax and Bak are capable of forming homo- and 
heterooligomers, thereby forming a pore, which lead to a limited 
permeabilization of the outer mitochondrial membrane and release of 
cytochrome c and apoptogenic factors, such as AIF, thereby leading to initiation 
of apoptosis (Jurgensmeyer et al., 1998; Kluck et al., 1999; Korsmeyer et al., 
2000; Petit et al., 1998; Susin et al., 1998). 
There exist at least 20 Bcl-2-related proteins in mammals and all of them 
possess at least one of four conserved motifs known as Bcl-2 homology 
domains (BH1 to BH4). Most anti-apoptotic Bcl-2 members contain BH1, BH2 
and BH3 domains, whereas Bcl-2 and Bcl-XL possess all four domains (Kelekar 
and Thompson, 1998). BH1,2 and 3 domains are required for their dimerisation, 
being essential for pore formation (Mikhailov et al., 2003; Muchmore et al., 
1996). The anti-apoptotic members located in the outer mitochondrial 
membrane inhibit apoptosis by preventing the opening of voltage-dependent 
anion channels (VDAC), which would lead to an influx of ions, followed by water 
influx and rupture of the outer mitochondrial membrane, releasing cytochrome c 
as a result (Narita et al., 1998; Shimizu et al., 1999).  
The pro-apoptotic members can further be divided into two subfamilies, 
members which contain BH1 to BH3 domains, such as Bax, Bak and Bok, and 
members containing solely the BH3 domain, such as Bik, Hrk, BimL, Noxa, Bad, 
Puma, Bmf and Bid (Adams and Cory, 1998; Reed et al., 1998). BH3-only 
proteins are expressed in many different cell types (Hsu et al., 1997; O´Reilly et 
al., 2000). They are primarily located in the cytoplasm and can relocalize to the 
outer mitochondrial membrane in response to an apoptotic stimulation, such as 
DNA damage, to induce cytochrome c release (Gross et al., 1998; 
Jurgensmeyer et al., 1998).  
Pro-apoptotic members, such as Bax and Bak, are able to form homo- 
and oligomers, as well as heterodimers by binding through their BH 3 domain 
(Chittenden et al., 1995). This leads to the release of cytochrome c and 
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activation of caspase 8, initiating the caspase cascade leading to apoptosis 
(Mikhailov et al., 2003). 
The BH3-only protein Bid is cleaved and activated by caspase 8, 
resulting in a tBid (Li et al., 1998). tBid itself can oligomerize with Bax or Bak 
forming large pores, thus releasing apoptogenic proteins, such as cytochrome c 
(Wei et al., 2000).  
In response to DNA damage, members of the PIKK family ATM and ATR 
are activated leading to phosphorylation serine 15 phosphorylation, following by 
enhanced expression of Bax or by Bax translocation to the mitochondria and 
reduced Bcl-2 expression (Miyashita et al., 1994; Miyashita and Reed, 1995; 
Thornborrow et al., 2002). This shifts the ratio between pro- and apoptotic Bcl-2 
family members, leading to a pro-apoptotic signal. Furthermore, p53 can 
activate caspase 8, which results in cleavage of Bid to tBid. tBid translocates to 
the mitochondria and promotes Bak and Bax assembly generating a transition 
permeability pore. This leads to apoptosome formation (Haupt et al., 2003), 
further activation of the caspase cascade and apotosis (Fig. 1.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Apoptosis signalling in response to p53 activation 
In response to DNA damage, p53 is activated, promoting the activation of Bax and inhibiting 
the transcription of Bcl-2. This shifts the ratio between pro- and antiapoptotic Bcl-2 familiy 
members leading to a pro-apoptotic signal further promoting apoptosis. IMM and OMM 
stands for inner  and outer mitochondrial membrane. 
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1.7 Objectives 
 
To elucidate the function of mammalian PLRG-1 in vivo, a conventional 
knockout of PLRG-1 in the mouse was generated using established gene 
targeting techniques. The targeting strategy resulted in a translational stop after 
12 aminoacids ensuring the ablation of the protein. Due to embryonic lethality of 
the conventional knockout, another conditional gene targeting vector was 
generated, in which exon 3 was flanked by loxP sites. This construct was 
introduced into V6.5 ES cells and correctly targeted clones were injected into 
blastocysts, leading to successful generation of chimeras and germline 
transmission of the conditional PLRG-1 allele (PLRG-1flox/+) onto following 
generations. Establishing homozygous loxP flanked mouse embryonic 
fibroblasts (MEF) enabled the functional characterization of PLRG-1 in vitro with 
the use of cell permeable Cre protein. The physiological role of PLRG-1 was 
defined by crossing mice carrying the conditional PLRG-1 allele with a muscle-
specific and a neuron-specific Cre reporter mouse strain to selectively ablate 
PLRG-1 in these tissues. 
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2 Materials and Methods 
 
 
2.1 Chemicals and antibodies 
 
 All chemicals used in this work are listed in table 2.1 and were mainly 
obtained from Sigma (Steinheim, Germany), Merck (Darmstadt, Germany) or 
Applichem (Darmstadt, Germany), if not otherwise stated. 
 Restriction enzymes were purchased from the following companies: 
Invitrogen (Karlsruhe, Germany), MBI Fermentas (St Leon-Rot, Germany), NEB 
(Schwalbach, Germany), Roche (Mannheim, Germany), and Takara (over 
Boehringer, Ingelheim, Germany). 
 Size markers for agarose gel electrophoresis were delivered from MBI 
Fermentas (Gene Ruler DNA Ladder Mix and λ/HindIII Marker). 
 Size marker for Pulsed-field gel electrophoresis was delivered from NEB 
(Yeast chromosome PFG marker). 
 Size marker for SDS-PAGE gel electrophoresis was purchased from MBI 
Fermentas (Prestained Protein Ladder Mix). 
 
Table 2.1: Chemicals 
Chemicals Company 
Agarose Peqlab, Erlangen, Germany 
Agarose Ultra Pure Invitrogen, Karlsruhe, Germany 
Agarose Pulse Field Certified Bio-Rad, München, Germany 
β-Mercaptoethanol Merck, Darmstadt, Germany 
Boric Acid Applichem, Darmstadt, Germany 
Bovine serum albumin (BSA) Applichem, Darmstadt, Germany 
Calciumchloride (CaCl2) Merck, Darmstadt, Germany 
Chloroform Applichem, Darmstadt, Germany 
Desoxy-ribonucleotid-triphosphates  Amersham, Freiburg, Germany 
Dextran sulfate Amersham, Uppsala, Sweden 
Dimethylformamide (DMF) Merck, Darmstadt, Germany 
Dimethylsufoxide (DMSO) Sigma-Aldrich, Steinheim, Germany 
Disodium hydrogen phosphate Applichem, Darmstadt, Germany 
Dithiothreitol (DTT) Aplichem, Darmstadt, Germany 
Ethanol, abs. Roth, Karlsruhe, Germany 
Ethidium bromide Applichem, Darmstadt, Germany 
Ethylendiamine tetraacetate (EDTA) Applichem, Darmstadt, Germany 
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Chemicals Company 
Fetal calf serum (FCS) for ES cells PAA, Pasching, Austria 
Fetal calf serum (FCS) for EF cells Invitrogen, Karlsruhe, Germany 
Gelatin, Type B  Sigma, Steinheim, Germany 
Glacial acetic acid Merck, Darmstadt, Germany 
Glycerin Applichem, Darmstadt, Germany 
Hepes Applichem, Darmstadt, Germany 
Hydrochloric acid (37 %) KMF Laborchemie, Lohmar, 
Germany 
Imidazole Applichem, Darmstadt, Germany 
Isopropyl-β-D-Thiogalacto-pyranoside 
(IPTG) 
Biomol, Hamburg, Germany 
Isopropanol (2-Propanol) Roth, Karlsruhe, Germany 
L (+)-Tartaric acid Sigma, Steinheim, Germany 
L-Arabinose Sigma. Steinheim, Germany 
L-Glutamine Invitrogen, Karlsruhe, Germany 
Luria-Bertani (LB) Agar Sigma, Steinheim, Germany 
Luria-Bertani (LB) Medium Applichem, Darmstadt, Germany 
Magnesiumchloride (MgCl2) Merck, Darmstadt, Germany 
Manganchlorid (MnCl2) Merck, Darmstadt, Germany 
Ni-NTA-agarose Qiagen, Hilden, Germany 
Nitrogen (liquid) (N2) Linde, Pullach, Germany 
N-Lauroylsarcosine  Sigma, Steinheim, Germany 
Non essentiell aminoacids (NEAA) Invitrogen, Karlsruhe, Germany 
α-P32-CTP Amersham, Freiburg, Germany 
Orange G Chroma Gesellschaft Schmidt & Co, 
Stuttgart, Germany 
Phenol/Chloroforme/Isoamylalkohol Applichem, Darmstadt, Germany 
Potassium chloride Merck, Darmstadt, Germany 
Potassium hydroxide Merck, Darmstadt, Germany 
Proteinase K  Roche, Switzerland 
Roswell Park Memorial Institute medium 
(RPMI) 
PAA, Pasching, Austria 
Salmon sperm DNA Biomol, Hamburg, Germany 
Sodiumacetate (NaOAc) Applichem, Darmstadt, Germany 
Sodiumchloride Applichem, Darmstadt, Germany 
Sodium-Citrate  Merck, Darmstadt, Germany 
Sodiumdodecylsulfat (SDS) Applichem, Darmstadt, Germany 
Sodiumhydroxide Applichem, Darmstadt, Germany 
Sodiumpyruvate Invitrogen, Karlsruhe, Germany 
Spermidin Sigma, Steinheim, Germany 
Trishydroxymethylaminomethan (Tris) Applichem, Darmstadt, Germany 
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2.2 Molecular biology 
 
 Standard methods in molecular biology were performed according to 
protocols published in Sambrook et al. (1989) 
 
 
2.2.1 Competent E.coli and isolation of plasmid DNA  
 
 Competent Escherichia coli DH5α cells were prepared according to the 
protocol of Inoue et al. (1990) and used for heat shock transformations.  
 Plasmid DNA was isolated from transformed E.coli using an alkaline lysis 
method (E.Z.N.A.® Plasmid Miniprep Kit 1, Peqlab, Erlangen, Germany) 
according to the protocol of Zhou et al. (1990).  
 
 
2.2.2 Construction of targeting vectors 
 
 All constructs used for vector generation were confirmed by sequencing. 
Primers used for the generation of targeting vectors are listed in table 2.2. 
 
 
Name Sequence (5´-3´) Purpose 
P1 
GTA GAC TAA ACG GCG 
GCG ACA TG 
Used for amplification of the 
short arm of homology for the 
conventional PLRG-1 
targeting vector 
P2 
GTG TGT GTA CAG AAT 
GCA TCT GTA CC 
Used for amplification of the 
short arm of homology for the 
conventional PLRG-1 
targeting vector 
P_long1_5 
GGC CGG CCA GGT CTT 
AAA GGT GCA TAC TCA 
CAG GAC 
Used for amplification of the 
long arm of homology for the 
conventional PLRG-1 
targeting vector 
Table 2.2: Oligonucleotides used for generation of gene replacement vectors and probes 
for Southern and Northern Blot 
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Name Sequence (5´-3´) Purpose 
P_long6_3 
CTC GAG GCA TCA ATG 
TCA CCA AAC CTG TAG 
CAC T 
Used for amplification of the 
long arm of homology for the 
conventional PLRG-1 
targeting vector 
KA5 
CGG CCG CGT AGA CTA 
AAC GGC GGC GAC ATG 
Used for amplification of the 
short arm of homology for the 
conditional PLRG-1 targeting 
vector 
KA3 
CCG CGG TCA AGG GTC 
CAA GTG AAT TAA AGA C 
Used for amplification of the 
short arm of homology for the 
conditional PLRG-1 targeting 
vector 
flExon3_5 
GGC GCG CCG GTC TCA 
TCC AAA AAG GTT TTG 
TGT 
Used for amplification of the 
loxP flanked exon 3 
flExon3_3 
GGC CGG CCG AAT CAA 
CTT GAG TTT TCC CTG 
TAG 
Used for amplification of the 
loxP flanked exon 3 
LA5 
CTC GAG CTA GCC TGT 
GGG GAG ACC ATC T 
Used for amplification of the 
long arm of homology for the 
conditional PLRG-1 targeting 
vector 
LA3 
GTT TAA ACA AAC ACC 
CTC TCA CGA GTG GGG 
Used for amplification of the 
long arm of homology for the 
conditional PLRG-1 targeting 
vector 
SB5A 
CAT TGC TGT ATC GGC 
GGT ACG TTT 
Used for amplification of 
probe A 
SB3A 
CTT GGT GCT CCT TAC 
TTG GAG GTT 
Used for amplification of 
probe A 
Neo5 
TGA ATG AAC TGC AGG 
ACG AGG CA 
Used for amplification of neo 
probe 
Neo3 
GCC GCC AAG CTC TTC 
AGC AAT AT 
Used for amplification of neo 
probe 
PLRGN5 
CAT CAG TAC AGT GCG 
TGG TGT GA 
Used for amplification of 
PLRG-1 northern probe 
PLRGN3 
CTA AAA TCG CTT TCT CTT 
GAT AAT TTC 
Used for amplification of 
PLRG-1 northern probe 
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2.2.3 TA-cloning 
 
 All PCR products used for gene replacement vectors were first 
introduced into the TOPO cloning vector (Invitrogen, Germany) using the TA-
overhangs generated by PCR following the manufacturer's protocols followed 
by sequencing. 
 
 
2.2.4 Generation of gene replacement vectors  
 
 All PCR products used for gene replacement vectors were cut out of the 
TOPO cloning vector containing the short arm of homology, long arm of 
homology and loxP flanked exon3, respectively, using the appropriate restriction 
endonucleases. Cloning was performed according to protocols published in 
Sambrook et al. (1989) and ligation of DNA fragments using the NEB T4-ligase 
according to the manufacturer’s protocol.  
 
 
2.2.5 Isolation of genomic DNA  
 
 Mouse tail biopsies or cultured cells were incubated overnight at 56°C in 
lysis buffer (10 mM Tris-HCl [pH 8]; 10 mM EDTA; 150 mM NaCl; 0.2% SDS; 
400 mg/ml proteinase K) on a thermomixer. DNA was precipitated by adding an 
equal volume of isopropanol, mixed and pelleted by centrifugation. The pellet 
was washed in 70% EtOH, dried, and resuspended in TE-buffer (10 mM Tris-
HCl [pH 8]; 1 mM EDTA) plus RNAseI (50 µg/ml). When used for Southern 
Blotting, DNA was resuspended in TE containing 50 µg/ml RNAse A. 
 Total DNA from ES cells grown in 96-well tissue culture dishes was 
extracted according to the protocol of Pasparakis and Kollias (1995). 
 For the preparation of DNA from mouse tissue, 100 mg tissue was 
incubated overnight at 56°C in tissue lysis buffer (0.1 M Tris-HCl, [pH 8.5]; 5 
mM EDTA; 0.2% SDS; 0.2 M NaCl; 1 g/ml proteinase K) on a thermomixer. 
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Debris was pelleted and the supernatant was mixed with an equal volume of 
phenol-chloroform followed by centrifugation. The upper, aqueous phase was 
transferred to a fresh tube and mixed with an equal volume of chloroform and 
centrifuged. Finally the upper phase was mixed with an equal volume of 
isopropanol and centrifuged to precipitate the DNA. The pellet was washed in 
70% EtOH, dried and resuspended in TE-buffer.  
 
 
2.2.6 DNA electrophoresis 
 
 DNA fragments were separated by size using electrophoresis in agarose 
gels (0.7% - 2%; 1xTAE; 0.5 mg/ml ethidiumbromide (Sambrook et al., 1989)). 
When desired, DNA fragments were excised using a scalpel, and eluted from 
agarose gel slices using the QIAEX II kit (QIAGEN, Hilden, Germany) following 
the manufacturer's protocol.  
 
 
2.2.7 Pulsed-field gel electrophoresis  
 
Pulsed-field gel electrophoresis (PFGE) provides the possibility to 
separate DNA ranging in size from a few kilobase pairs up to 10 megabase 
pairs. Because of the large size of these molecules, cell lysis has to occur in 
agarose embedded plugs. This prevents shearing of the DNA which could lead 
to diminished quality of the PFGE separations. To generate agarose embedded 
plugs, the CHEF Genomic DNA Plug Kit from Bio-Rad was used according to 
manufacturer’s protocol. 106 mouse embryonic fibroblasts were embedded in 
100 µl agarose plugs and used for PFGE using the CHEF-DR II system from 
Bio-Rad. A 1% agarose gel (Pulse Fiel Certified Agarose, Bio-Rad, München, 
Germany) was run at 6 V/cm2 using pulse times of 70 s for 15 h, followed by 
120 s for additional 11 h in 0.5% TBE buffer containing 50 mM Tris-HCl, 50 mM 
boric acid and 1 mM EDTA. After running, the gel was stained with EtBr to 
visualize the DNA. 
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2.2.8 DNA sequencing 
 
 DNA was sequenced using the 'Big Dye termination Cycle Sequencing 
Kit' (Applied Biosystems, Foster City, USA), which is a PCR-based modification 
of the original Sanger protocol (Sanger et al., 1977). The DNA fragments were 
analysed automatically using the ABI373A and ABI377 systems (Applied 
Biosystems, Foster City, USA).  
 
 
2.2.9 Quantification of DNA 
 
 The concentration of nucleic acids was determined by measuring the 
absorption of the sample at 260 nm and 280 nm in a spectrophotometer. An 
OD260 of 1 corresponds to approximately 50 µg/ml for double stranded DNA. 
Purity of nucleic acids was estimated by calculating the ratio OD260/OD280. Pure 
nucleic acids show a ratio OD260/OD280 of 2. Protein contaminations decrease 
this value. Samples with a quotient between 1.8 and 2 are pure enough for DNA 
quantification. 
 Residual glass milk from the QIAEX II kit interferes with UV absorption, 
hence, for estimating the concentration of DNA fragments extracted from 
agarose gels, a small sample of the DNA was again subjected to 
electrophoresis, and the concentration was compared to the band intensity of a 
standard marker.  
 
 
2.2.10 PCR 
 
 The Polymerase Chain reaction (PCR) was used for in vitro amplification 
of DNA fragments, e.g. for generation of targeting vectors, detecting the 
presence of targeted alleles or generating fragments for sequencing (Saiki et 
al., 1985; Saiki et al., 1986). Reactions were performed in Thermocycler iCycler 
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PCR machine from Bio-Rad or in Peltier Thermal Cycler PTC-200 from MJ 
Research. 
 Genotyping of cells and mice was performed in a total volume of 25 µl 
containing 250 ng DNA, 25 pmol of each primer, 25 µM dNTP´s, 1.5 mM MgCl2, 
0.75 U Thermus aquaticus (Taq) Polymerase (homemade), 10 mM Tris-HCl pH 
8.3, 50 mM KCl. PCR started with an initial denaturation at 94°C for 5 min, 
followed by 30-35 repeating cycles of denaturation at 94°C for 30 s, annealing 
at 54-57°C for 30 s, elongation at 72°C for 1 min and a final extension step of 
10 min at 72°C. 
 Genotyping of blastocycts, 2-cell stage embryos and fertilized oocytes 
was performed using a semi-nested PCR (Fig. 2.1). The first PCR generates a 
large amount of specific DNA fragments using primers for the wildtype (W5.1, 
W3.2) and the targeted allele (W5.1, 1.2 rev1). These products are used in the 
second PCR as template. Here, the PCR was performed by using a different 
internal 5´ primer (W5.2) and the same 3´ primers (W3.2, 1.2 rev1). This 
technique allows the analysis of a single cell, so the first PCR reaction 
contained one blastocyste, morula or fertilized oocyte, 25 pmol of each primer, 
23.5 µl ddH2O and 25 µl of a mastermix obtained from Roche. The PCR started 
with an initial denaturation at 94°C for 2 min, followed by 25 repeating cycles of 
denaturation at 94°C for 15 s, annealing at 54°C for 30 s, elongation at 72°C for 
1 min followed by another round of additional 35 repeating cycles of 
denaturation at 94°C for 20 s, annealing at 54°C for 30 s, elongation at 72°C for 
1.5 min and a final extension step of 10 min at 72°C. 2 µl of the first PCR were 
used as template for the second PCR, containing 25 pmol of each primer, 22 µl 
ddH2O and 25 µl mastermix. This second PCR started with an initial 
denaturation at 94°C for 2 min, followed by 15 repeating cycles of denaturation 
at 94°C for 15 s, annealing at 54°C for 30 s, elongation at 72°C for 1 min and 
additional 25 repeating cycles of denaturation at 94°C for 20 s, annealing at 
54°C for 30 s, elongation at 72°C for 1.5 min and a final extension step of 10 
min at 72°C. 
 Amplification of DNA fragments for targeting vectors was performed 
using the High Fidelity Kit from Roche according to the manufacturer´s 
guidelines. Primers used for genotyping are listed in table 2.3. 
 
Materials and Methods   
28 
primer 1
700 bp
1 2 3 4
primer 2
2. PCR:
5
1. PCR:
350 bp
2 3
primer 3 primer 2
 
 
Table 2.3: List of primers used for genotyping 
Name Sequence(5´-3´) TAnn.°C Location direction 
W5.1 
GCC AGA CAG 
GAG CTT TCT CAT 
54 Intron 1 sense 
W5.2 
CCT TCT CCA TAT 
TTA GCG TGG 
54 Intron 1 sense 
W3.1 
CCT CTC TTC ATC 
CAA AGG CAC 
54 
Boundary 
Exon2/Intron2 
antisense 
W3.2 
TCT CTC TGC ACC 
CTT CTG TTA 
54 Intron 2 antisense 
1,2rev1 
CCT ACC GGT 
GGA TGT GGA 
ATG TG 
55 
PGK promotor of 
neor 
antisense 
Flp5 
GAC AAG CGT 
TAG TAG GCA CAT 
61 
N-terminal part 
of FLP cDNA 
sense 
Flp3 
GAG AAG AAC 
GGC ATA GTG 
CGT 
61 
C-terminal part 
of FLP cDNA 
antisense 
LA2 
TGT TAT GTG CAG 
TGC CTT TCT 
55 Intron 1 sense 
Seq4 
GTC CTC TGT CCA 
AGC ATA TTT G 
55 Intron 3 antisense 
MCK5 
GTT CTT AAG TCT 
GAA CCC GG 
60 MCK promotor sense 
Figure 2.1: Schematic 
representation of 
semi-nested PCR 
method 
Genomic DNA serves 
as a DNA template for 
the first PCR. The PCR 
product of the first PCR 
serves as a DNA 
template for the 
second PCR.  
Note: Primer names 
and sizes of bands are 
fictitious.  
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Name Sequence(5´-3´) TAnn.°C Location direction 
MCK3 
GTC TGG ATG ACA 
TCG TCC AG 
60 
N-terminal part 
of MCK 
antisense 
Cre_intern_rev 
ATG TTT AGC TGG 
CCC AAA TGT 
60 
N-terminal part 
of Cre 
antisense 
Syn5 
TTC CCG CAG AAC 
CTG AAG ATG TTC 
G 
 
59 
N-terminal part 
of SYNCre cDNA 
sense 
Syn3 
GGG TGT TAT AAG 
CAA TCC CCA GAA 
ATG C 
 
59 
C-terminal part 
of SYNCre cDNA 
antisense 
Lox5 
TGT GAT GGT 
GGC CGT ATT GAT 
54 
(Intron3) 
Between Exon3 
and 3´loxP site 
sense 
Lox3 
CTG TTC CAG CTG 
TTC TTC ACA 
54 Intron3 antisense 
 
Sequences of oligonucleotides are shown in 5’-3’direction. Direction is designated “sense”, if the 
primer orientation coincides with transcriptional direction, and “anti-sense” vice versa. 
 
 
2.2.11 RT-PCR and quantitative Real-Time PCR 
 
RNA from mouse embryonic fibroblasts was isolated using the RNeasy 
mini kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol. 
DNase treatment of RNA was performed prior to RT-PCR using the RQ1 
Rnase-Free Dnase I endonuclease according to the manufacturer’s guidelines 
(Promega, Mannheim, Germany). 200 ng total RNA per reaction was used for 
cDNA synthesis using the One step RT qPCR Master Mix from Eurogentec. 1 µl 
of cDNA was used for PCR with exon spanning primers (Tab. 2.4) 
Quantitative Real-Time PCR was performed using the qPCR Mastermix 
Plus without UNG kit from Eurogentec with a TaqMan Principles ABI Prism 
7700 Sequence Detection System. Relative expression of mRNAs was 
determined using standard curves based on MEF cDNA. Samples were 
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adjusted for total RNA content by TBP RNA quantitative PCR. Calculations 
were performed by a comparative method (2-δδCT). Used samples for 
quantitative Real-Time PCR are listed in Tab. 2.5. 
 
Table 2.4: List of oligonucleotides used for amplification of cDNA 
Name Sequence(5´-3´) TAnn.°C Location direction 
5CycD1 
CTT GAC TGC CGA 
GAA GTT GTG 
54 Exon 2 sense 
3CycD1 
AAG TGT TCG ATG 
AAA TCG TGG 
54 Exon 3 antisense 
5CycE1 
CTG GGA TGA TAA 
TTC AGC ATG 
54 Exon 5 sense 
3CycE1 
AAA GTG CTC ATC 
TCT CAG GTA 
54 Exon 6 antisense 
p53-5RT 
AGT CAC AGC ACA 
TGA CGG AGG 
54 Exon 5 sense 
p53-3RT 
TGC CTG TCT TCC 
AGA TAC TCG 
54 Exon 6 antisense 
 
Sequences of oligonucleotides are shown in 5’-3’direction. Direction is designated “sense”, if the 
primer orientation coincides with transcriptional direction, and “anti-sense” vice versa. 
 
 
Table 2.5: List of probes used for quantitative Real-Time PCR 
Gene name Abbreviation Order number 
DNA-damage inducible 
transcript 3 
Ddit 3 Mm00492097_m1 
Forkhead box 1 Foxo 1 Mm00490672_m1 
Forkhead box 3a Foxo 3a Mm00490673_m1 
Notch1 Notch1 Mm00435245_m1 
Transforming growth 
factor beta 1 
TGF-β1 Mm00441724_m1 
Tubulin alpha 1 Tuba 1 Mm00846967_g1 
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2.2.12 DNA hybridization 
 
 10 µg of genomic DNA were digested overnight using 100 U of the 
appropiate restriction enzyme and separated on a 0.8% agarose gel. DNA was 
subsequently transferred and immobilized on a nylon membrane (Hybond-N+, 
Amersham) using an alkaline capillary transfer (Chomczynski and Qasba 1984). 
To crosslink the DNA with the membrane, membranes were baked at 80°C for 
30 min, equilibrated in 2xSSC (Sambrook et al., 1989) and prehybridized at 
65°C for 2-4 h in hybridization solution (1M NaCl, 1% SDS, 10% dextran sulfate, 
50 mM Tris-HCl pH 7.5, 250 µg/ml sonicated salmon sperm DNA). Probes were 
labeled with α32P-dCTP using the LaddermanTM DNA Labeling Kit (TaKaRa, 
Otsu, Japan) according to the manufacturer´s guidelines. Hybridization of the 
probe was performed overnight at 65°C. The membranes were washed several 
times with 2xSSC/0.1% SDS at 65°C until radioactive signals determined with a 
handheld Geiger counter reached 50 cps. Subsequently, the membrane was 
sealed in a plastic bag and exposed to an X-ray film (BioMAX MS; Kodak) 
overnight at -80°C. Films were developed in an automatic developer. 
Alternatively, membranes were exposed to a phosphoimager screen (Fuji, Fuji, 
Japan) and analyzed on a Bio-Imaging Analyser (Fuji Bias 1000; Fuji, Japan).  
 The following probes were used: 
1. A PLRG-1 5´probe was PCR amplified from a PLRG-1 BAC using 
primers SB5A and SB3A resulting in a 498bp fragment. 
2. A Neomycine resistance gene probe was PCR amplified from pGK12 
vector using primers Neo5 and Neo3 resulting in a 510bp fragment. 
 
 
2.2.13 Northern Blot and RNA hybridization 
 
 RNA blots from mouse adult tissue (N1334447-BC) and different embryo 
stages (R1011-SG) were purchased from BioCat. Blots were hybridized with a 
radiolabeled PLRG-1 probe. 
 The membrane was prehybridized at 68°C for 2 h in prehybridization 
solution (Express Hyb, Stratagene, Heidelberg, Germany). A probe was labeled 
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with α32P-dCTP using the LaddermanTM DNA Labeling Kit (TaKaRa, Otsu, 
Japan) according to the manufacturer´s guidelines. Hybridization of the probe 
was performed overnight in hybridization solution (Express Hyb, Stratagene, 
Heidelberg, Germany) containing 100 µg/ml salmon sperm DNA. After 
hybridization, membranes were washed several times in 2xSSC/0.1% SDS until 
radioactive signals reached 50 cps. Membranes were sealed in plastic bags and 
exposed to an X-ray film (BioMAX MS; Kodak) overnight at -80°C. 
 The following probe was used: 
1. A PLRG-1 5´probe was PCR amplified from bl/6 mouse tail DNA using 
primer PLRGN5 and PLRGN3 resulting in a fragment of 753bp. 
 
 
2.3 Cell culture 
 
2.3.1 Primary embryonic fibroblast (EF) culture 
 
 Primary EF cells were obtained from mouse embryos at day 13.5 day 
p.c. 
 Mice of the desired genotypes were mated and pregnancy was verified 
by the occurence of vaginal plugs. 13.5 days after mating, the pregnant mice 
were sacrificed by cervical dislocation. The mouse was desinfected using 
Bacillol (Bode Chemie, Hamburg, Germany), the abdomen opened and the 
uterus containing the embryos dissected. The embryos and placentae were 
placed in PBS containing 10% Beta-Isodona (Bode Chemie, Hamburg, 
Germany) and after removal of the placenta embryos were transferred into 
PBS/7,5% Beta-Isodona. Heart, liver and brain were removed and the residual 
tissue was placed in PBS, strained through a sterile nylon sieve and washed 
with EF-medium (Dulbecco´s modified Eagle´s medium (DMEM) containing 
stable glutamine (Glutamax), 10% FCS, 4500 mg/l glucose, and 1xnon-
essential amino acids). The cells were pelleted, resuspended in medium, plated 
on a 10 cm tissue culture dish (Falcon, Bedford, USA) and grown at 37°C in an 
atmosphere of 10% CO2. Primary EF cells were used only up to passage 20. 
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2.3.2 Embryonic stem (ES) cell culture 
 
 For all transfections V6.5 (129Sv x C57BL/6) Embryonic stem cells 
(Eggan et al., 2002) were used. ES cells were grown at 37°C in an atmosphere 
of 10% CO2 in Dulbecco´s modified Eagle´s medium (DMEM) containing 15% 
fetal calf serum (FCS), 4500mg/l glucose, 1xnon-essential amino acids, 2 mM 
glutamine, 1 mM Na-pyruvat, 0.01 mM ß-mercaptoethanol, and 1.3 ml leukemia 
inhibitory factor. Cells were grown on mitotically inactivated feeder cells, which 
had been treated with mitomycin C (10 µg/ml for 2 h) and washed extensively 
with PBS before seeding with ES cells 
 ES cell colonies were trypsinized before they reached confluency or after 
three days. Therefore, cells were washed with PBS and treated with trypsin 
(0.05 % trypsin, 0.02 % EDTA in PBS; Gibco, Karlsruhe, Germany) for 3 min at 
37°C. Trypsin was stopped by adding an equal amount of ES-medium 
containing FCS to the cells and centrifugation. ES cells were passaged to fresh 
plates, transfected or frozen (in 90% FCS, 10% DMSO at -80°C, transfer to 
liquid nitrogen the next day). 
 For transfection, 1x107 ES cells were mixed with 40 µg DNA in 800 µl 
transfection buffer (RPMI w/o phenol red, Gibco, Karlsruhe, Germany) in a 
prechilled electroporation cuvette. For electroporation 500 µF and 240 V at 
23°C as standard conditions were used. ES cells were allowed to recover for 5 
min on ice prior to seeding on 4x10 cm tissue culture dishes containing an 
embryonic feeder cell layer.  
 48 h after transfection, positive selection started using 250 µg/ml G418 
(Gibco, Karlsruhe, Germany). Negative selection against HSV-tk containing 
random integrants started at day five by adding 2x10-6 M gancyclovir (Cymeven, 
Syntex, Aachen, Germany) to the medium. On day 9 and 10 after transfection, 
double resistant colonies were picked from the culture dishes using yellow 
pipette tips and seeded into EF-containing 96-well tissue culture dishes for 
recovery and expansion. 3 days after picking the clones, cell samples were 
frozen, and in parallel expanded for DNA extraction. 
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2.3.3 HTN-Cre-mediated deletion in vitro 
 
 Fibroblasts were treated with His-TAT-NLS-Cre (HTNC) to delete loxP-
flanked gene segments, which was purifed according to Peitz et. 2002  
 3x106 cells were plated on a 15 cm cell culture dish. After 4 h, cells were 
washed twice with PBS and incubated with 5 µM HTN-Cre dissolved in 
DMEM/PBS. 16 h later, cells were washed with PBS and passaged for the 
respective experiments. 
 
 
2.3.4 Cell cycle analysis 
 
 HTNC-treated fibroblasts were grown to confluence, washed twice with 
PBS, serum deprived for 48 h, left untreated or stimulated with 10% FCS for 2, 
4, 6, and 8 h, respectively. Cells were trypsinized and counted using an 
improved Neubauer Haemocytometer. 106 cells were lysed in 500 µl 2xSDS 
sample buffer containing 125 mM Tris-HCl [pH 6.8], 5% SDS, 43.5% glycerol, 
100 mM DTT, and 0.02% bromophenol blue and used for immunoblotting. 
 
 
2.3.5 Cell cycle analysis using fluorescence-activated cell sorter (FACS) 
analysis 
 
 106 HTNC-treated fibroblasts were cultured in the absence of serum for 
24 h and left untreated or stimulated with 10% FCS for 24 h. Cells were 
collected by trypsin digestion and fixed in ice-cold 70% EtOH in PBS for at least 
2 h. After the removal of ethanol, cells were washed once with PBS, and 
incubated with 500 µl propidium iodide (PI) staining solution containing 0.1% 
Triton X-100 (Sigma), 200 µg/ml DNase-free RNase A (Sigma), and 20 µg/ml 
Propidium Iodide (Sigma) in PBS. 25000 cells were analyzed by FACS 
(FACSCalibur, Becton-Dickinson Biosciences Immunocytometry Systems) and 
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the proportion of cells in the G0/G1, G2/M, and S phase was assessed using the 
CellQuest software (Becton Dickinson, Mountain View, USA).  
 
 
2.3.6 3H-thymidine incorporation 
 
 HTNC-treated fibroblasts were trypsinized and counted using a 
Neubauer Haemocytometer. 104 cells were seeded per well (200 µl/well Æ 
5x104/ml) onto a 96-well tissue culture dish and serum deprived overnight. The 
following day medium was removed and cells were washed once with PBS. 
Fresh MEF or starving medium containing 5 µCi/ml 3H-thymidine was added to 
to the. MEFs were incubated with 100 µl of these prepared media for 0, 16 and 
24 h. Thereafter, cells were washed with PBS and trypsinized. MEFs were 
harvested and fixed onto self aligning glass fiber filters (Packard Instrument 
Company, Downers Grove, USA ) using the Packard Harvester Filtermate 196 
harvester (Packard Instrument Company, Downers Grove, USA) and airdrying 
of filters. Incorporated 3H-thymidine was measured using liquid scintillation 
counter (Packard Topcount microplate scintillation counter). Counts per minute 
were used as the readout for proliferation. Calculating the quotient of serum 
added and serum deprived 3H-thymidine containing medium resulted in 
proliferative capacity. For all experiments 48 wells were used for each condition, 
to receive low standard abbreviations. 
 
 
2.3.7 Analysis of apoptosis 
 
 To assess apoptosis, a TUNEL assay (DeadEndTM Fluoromteric TUNEL 
System, Promega) was used. HTNC-treated fibroblasts were cultivated on glass 
coverslips in a 6-well plate for 3 days after Cre-treatment. Thereafter, cells were 
fixed in 4% formaldehyde for 25 min at 4°C and washed twice in PBS. TUNEL 
assays were performed according to the manufacturer´s guidelines. Percentage 
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of apoptotic cells was calculated as TUNEL-positive cells per DAPI-stained 
nuclei. 
 
 
2.3.8 DNA double-strand breaks after UV-treatment 
 
To determine the occurrence of DNA double-strand breaks, 106 HTNC-
treated mouse embryonic fibroblasts were left either untreated or broadband UV 
irridated for 2 min using a UV transilluminator (Gel Doc EQ System, München, 
Germany). Non- and UV-irridated cells were cultivated for additional 24 h, 
harvested, agarose embedded (CHEF Genomic DNA Plug Kit, Bio-Rad, 
München, Germany) and analyzed by PFGE. 
 
 
2.3.9 Immunofluorescence 
 
HTNC-treated fibroblasts were cultivated on glass coverslips in a 6-well 
plate for 2 days after Cre-treatment. Thereafter, cells were fixed in 4% 
paraformaldehyde for 10 min at RT and washed 3 times with PBS. Cells were 
permealized with 0.5% Triton X-100 and additionally washed another 3 times 
with PBS. Subsequently, fixed and permealized fibroblasts were blocked with 
0.5% BSA in PBS for 45 min at RT. Samples were incubated for 1 hour at RT 
with an 1:500 γ-H2AX antibody (JBW 301, Millipore, Billerica, USA) dilution in 
0.5% BSA/PBS. Following, samples were washed 4 times with PBS, incubated 
for 45 min at RT with an 1:3000 Alexa-Fluor 555 antibody (Invitrogen, Carlsbad, 
USA) dilution in 0.5% BSA/PBS and kept in dark. Cells were stained with DAPI 
in Vectashield to visualize nuclei. Percentage of γ-H2AX positive cells was 
calculated per DAPI-stained nuclei. 
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2.3.10 RNA interference (RNAi) 
 
 RNAi-mediated knockdown of endogenous PLRG-1 and p53 was 
performed using Lipofection. PLRG-1 siRNA was purchased from Ambion 
(16704) and p53 siRNA was purchased from Santa Cruz (sc-44219, sc-29436). 
si-CONTROL from Dharmacon (D-001210-01) was used as control siRNA. 
These siRNA duplexes (25 nM) were introduced into MEFs using Lipofectamine 
2000 (Invitrogen, Germany) following the manufacturer´s guidelines. 48 h after 
transfection, cells were harvested and used for TUNEL assay and 
immunoblotting. 
 
 
2.4 Biochemistry 
 
2.4.1 Protein extraction from tissue 
 
 100-500 mg tissue were dissolved in 1 ml lysis buffer containing 50 mM 
HEPES [pH 7.4], 1% Triton X-100, 0.1% SDS, 100 mM NaF, 10 mM Na3O4V, 
250 mM EDTA, 50 mM NaCl, 10 µg/ml aprotinin, 2 mM benzamidin, 348 µg/ml 
PMSF, and homogenized using a Ultra Thurrax homogenizer. Protein extracts 
were centrifuged for 45 min at 4°C to separate supernatants from debris. 
Protein concentration was measured using a photometer and the Christian-
Warburg formula. 10 µg/µl protein stock solution was prepared in 1xSDS 
sample buffer and heated at 95°C for 5 min. 100µg protein were used for 
immunoblotting. Protein solutions were always stored at -80°C. 
 
 
2.4.2 Protein extraction from cells 
 
 Collected samples of cells were directly lysed in 2xSDS sample buffer 
containing 125 mM Tris-HCl [pH 6.8], 5% SDS, 43.5% glycerol, 100 mM DTT, 
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and 0.02% bromophenol blue and heated at 95°C for 5 min. Lysates of 5x104 
cells were loaded and fractionated on 10-15% SDS-PAGE gels. Alternatively, 
5x105 cells were lysed in 250 µl 2xSDS sample buffer and heated at 95°C for 5 
min. Protein extracts were directly used for SDS-PAGE gel electrophoresis or 
frozen at -80°C. 
 
 
2.4.3 Nuclear and cytoplasmic protein extraction 
 
 Embryonic fibroblasts were washed with PBS. 106 cells were 
resuspended in 15 µl hypotonic buffer A containing 10 mM HEPES [pH 7.6], 10 
mM KCl, 2 mM MgCl2, 0.5 mM DTT, 0.1 mM EDTA, and 1 tablet of Proteinase 
Inhibitor (Complete mini, Roche, Germany) and incubated for 10 min at 4°C. 
NP40 were added to a final concentration of 1% and incubated at 4°C for 1 min. 
Cells were immediately collected by centrifugation at 13000rpm at 4°C for 1 
min. The supernatant contained the cytoplasmic fraction. The pellet was 
washed with buffer A and resuspended in 10 µl high salt buffer B containing 50 
mM HEPES [pH 7.8], 50 mM KCl, 300 mM NaCl, 0.5 mM DTT, 0.1 mM EDTA, 
10% glycerol, and 1 tablet of Proteinase Inhibitor (Complete mini, Roche, 
Germany). The pellet was incubated at 4°C on a full speed shaker for 1 h. After 
incubation, the suspension was centrifuged at 13000 rpm at 4°C for 1 h. The 
supernatant contained the nuclear fraction. 
 
 
2.4.4 Immunprecipitation 
 
 150 µg nuclear proteins were incubated with 2 µg of anti-WIP1 or anti-
insulin receptor (negative control) antibody at 4°C on a rotator for 1 h. Then, 
100 µl of Protein A-Sepharose (100 mg/ml, Amersham, Freiburg, Germany) 
were added and incubated overnight. The suspension was washed 5 times with 
high salt buffer B, 50 µl 2xSDS loading buffer was added, and samples were 
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incubated for 5 min at 95°C. The samples were separated on SDS-PAGE gels, 
and processed for western blot analysis. 
 
 
2.4.5 Western Blot 
 
 Proteins were fractionated on 10-15% SDS-PAGE gels (Laemmli, 1970) 
and semi-dry blotted onto a PVDF-membrane for 30 min to 1 h using a current 
of 200 mA. Unspecific binding sites were blocked with 1% blocking solution in 
1x TBS (20mM Tris [pH 7.6], 0.14 M NaCl) (Amersham, Freiburg, Germany) for 
1 h at RT and incubated with appropriate primary antibodies at 4°C overnight 
(table 2.6). Membranes were washed 4 times for 10 min with TBS-T (1x TBS, 
0,1% Tween 20), incubated with respective secondary antibodies, which were 
coupled to horseradish peroxidase (HRP), at RT for 1 h. Membranes were 
washed again 4 times for 10 min with TBS-T and signals were detected using 
the ECL kit (Amersham, Freiburg, Germany). 
 
Table 2.6: Antibodies used for biochemical studies 
Specificity Order number Company 
AKT 9272 Cell signaling 
β-Actin 1616 Sigma 
Bax N-20, sc 493 Santa Cruz 
Bcl-2 N-19, sc 492 Santa Cruz 
CDC5L 612362 BD Transduction Laboratories
cleaved Caspase 3 9661 Cell Signaling 
Cyclin D1 sc 718 Santa Cruz 
Cyclin E C-19, sc 198 Santa Cruz 
IR-ß C-19, sc 711 Santa Cruz 
Lamin A/C N-18, sc 6215 Santa Cruz 
p21 C-19, sc 397 Santa Cruz 
p44/42 MAP kinases 9102 Cell Signaling 
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Specificity Order number Company 
pp44/42 MAP kinases 9106 Cell Signaling 
p53 FL-393, sc 6243 Santa Cruz 
p-S15-p53 GTX 21431 Gene Tex 
PLRG-1 selfmade Received from Dr. Paul Ajuh 
WIP1 H-300, sc 20712 Santa Cruz 
 
 
 Secondary antibodies were peroxidase-coupled goat anti-rabbit IgG 
(whole molecule), anti-goat/sheep IgG (whole molecule) (Sigma), and anti-
mouse IgG (whole molecule) (Amersham). 
 
 
2.4.6 Immunohistochemistry 
 
 Brains were dissected from 2 to 3 day old mice and snap frozen in tissue-
freezing medium (Jung Tissue Freezing Medium; Leica Microsystems, 
Germany). Sections were performed using a cryostat. Brain slices were either 
stained with H&E or used for TUNEL assays following manufacturer´s 
guidelines.  
Hearts were dissected from 3 week old mice, frozen in tissue-freezing medium 
(Jung Tissue Freezing Medium; Leica Microsystems, Germany) and sectioned 
on a cryostat. Sections were either stained with H&E or processed for TUNEL 
assays. 
 
 
2.5 Statistical methods 
 
 Data was analyzed for statistical significance using a two-tailed unpaired 
student’s T-Test. 
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2.6 Animal Care 
 
 Care of all animal was within institutional animal care committee 
guidelines. All animal procedures were conducted in compliance with protocols 
and approved by local government authorities (Bezirksregierung Köln, Cologne, 
Germany) and were in accordance with NIH guidelines. Mice were housed in 
groups of 3 to 5 at 22–24°C using a 12 h light/dark cycle. 
 
 
2.6.1 Mouse experiments 
 
 General handling and breeding of mice was performed according to 
Hogan (Hogan et al., 1987) and Silver (Silver, 1995). 
 
 
2.6.2 Mice 
 
 C57BL/6 and CB20 mouse strains were ordered from Charles River, 
Taconic or Jackson Laboratories. Flp deleter mice (Rodriguez et al., 2000) were 
obtained from our animal facility. PLRG-1∆/+ mice were intercrossed to receive 
homozygous PLRG-1∆/∆ mice. MCKCre mice (Brüning et al., 1998) were mated 
with PLRG-1flox/flox mice, and a breeding colony was maintained by mating 
PLRG-1flox/flox with PLRG-1flox/+MCKCre mice. SynCre mice (Zhu et al., 2001) 
were mated with PLRG-1flox/flox mice, and a breeding colony was maintained by 
mating PLRG-1flox/flox with PLRG-1flox/+SynCre mice. The SynCre was always 
transmitted from females, as the transgene has previously been demonstrated 
to result in germline deletion if transmitted via male germ cells (Rempe et al, 
2006).
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3 Results 
 
 
 The protein pleiotropic regulator PLRG-1 was identified as a 
spliceosomal component in vitro, but its functional roIe in vivo until now has not 
been examined. To elucidate the function of PLRG-1 in vivo, we generated a 
gene replacement vector to inactivate the murine PLRG-1 gene. The resulting 
heterozygous PLRG-1∆/+ mice exhibited no apparent phenotype, but analysis of 
the offspring from PLRG-1∆/+ intercrosses at postnatal day 21 indicated an 
absence of PLRG-1∆/∆ mice. Detailed inspection of litters at different stages of 
embryogenesis revealed that homozygous PLRG-1-deficient early embryos 
were only detectable until embryonic day 1.5.  
 To determine whether early embryonic lethality caused by the PLRG-1 
mutation is due to a general cell cycle defect also manifested in somatic cells, a 
second gene replacement vector for conditional Cre-loxP-mediated inactivation 
of PLRG-1 was generated. This allowed a functional characterization of PLRG-1 
in vivo, circumventing embryonic lethality and enabling analysis of PLRG-1 
deletion in a tissue specific manner. In addition, a line of embryonic fibroblasts, 
homozygous for the loxP-flanked allele of PLRG-1, was established for in vitro 
studies. In these cells, deletion of PLRG-1 is achieved through HTN-Cre 
application. 
 To obtain mice lacking PLRG-1 specifically in skeletal muscle and heart, 
PLRG-1flox/+ mice were crossed with mice expressing a  Cre recombinase under 
control of the muscle specific creatinine kinase (MCK)-promoter (Bruning et al., 
1998). Double-heterozygous PLRG-1flox/+MCKCre mice were crossed with 
PLRG-1flox/flox mice to obtain PLRG-1flox/floxMCKCre offspring, i.e. mice lacking 
PLRG-1 expression in skeletal muscle and heart (PLRG-1∆mus) 
PLRG-1 was also inactivated in the central nervous system (CNS) by 
intercrossing PLRG-1flox/flox mice with mice expressing a Cre recombinase under 
control of the synapsin promoter (Zhu et al., 2001). PLRG-1flox/flox mice were 
crossed with double-heterozygous PLRG-1flox/+SynCre mice to obtain PLRG-
1∆CNS mice with neuron-restricted PLRG-1 deficiency. 
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 Analysis of different mouse lines with distinct tissue specific PLRG-1 
ablation and studies with homozygous loxP-flanked mouse embryonic 
fibroblasts enabled the gain of novel insights into the function of PLRG-1 in vivo 
and in vitro. 
 
 
3.1 Murine expression pattern of PLRG-1 
 
 In order to determine the expression pattern of the pleiotropic regulator 
gene 1 (PLRG-1) in C57BL/6 wild type mice, Northern Blot analysis was 
performed using a PLRG-1 cDNA probe. This analysis revealed the ubiquitous 
expression of PLRG-1 in all tested organs of adult mice with highest levels in 
thymus, testis, kidney, brain and spleen (Fig. 3.1A).  
 In addition, a murine embryo stage Northern blot, containing RNA from 
embryos of day 4.5 to 18.5, was performed, revealing that PLRG-1 is expressed 
throughout all phases of mouse embryonic development, showing a peak of 
steady-state mRNA levels between embryonic days (ED) 10.5 and 14.5 (Fig. 
3.1B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
Figure 3.1: Ubiquitous expression of PLRG-1 
Northern RNA hybridization analysis of PLRG-1 expression in mice. 
(A) Expression analysis of PLRG-1 in tissues from adult mice. 
(B) Expression of PLRG-1 in the developing mouse embryo. (ED: embryonic day).  
Upper panels show hybridization of the PLRG-1 probe, the lower panels display the 
corresponding 18S and 28S RNA as loading controls. 
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3.2 Generation of a conventional PLRG-1 gene replacement vector 
 
 The murine gene coding for PLRG-1 comprises 15 exons and spans 
17kb of genomic DNA. The C-terminal part of the protein consists of a 
conserved WD-40 domain of 7 WD-40 repeats. The WD-40 domain is part of 
many components of multiprotein-complexes and is responsible for protein-
protein interactions. The N-terminal part of PLRG-1 is not conserved across 
different species and contains no known motifs.  
To disrupt the PLRG-1 gene using conventional gene targeting 
techniques, a neomycin resistance cassette was inserted into the second exon 
of the murine PLRG-1 gene (Fig. 3.2A). This insertion caused a frame shift and 
a subsequent translational stop of the protein after 12 amino acids. The PLRG-1 
targeting vector was generated using the pGK12 vector (Artemis 
Pharmaceuticals, Köln, Germany), which contains a PGK neomycine resistance 
cassette, as a positive selection marker, and the Herpes Simplex virus 
thymidine kinase (TK) gene, as a negative selection marker.  
 The 1.2 kb short arm of homology comprising exon 1, intron1 and the first 
27 bp of exon 2 was amplified from C57BL/6J BAC DNA via PCR. The BAC 
(RP23-333D8) was constructed in the laboratory of Kazutoyo Osoegawa and 
Minako Tateno from pooled tissues derived from three female C57BL/6J mice 
(Osoegawa et al., 2000). The oligonucleotides P1 and P2, used for this PCR, 
harboured restriction sites allowing a direct cloning into NotI and BamHI sites of 
the the pGK12 vector after an intermediate subcloning into the TOPO cloning 
vector (Invitrogen, Karlsruhe, Germany). After a control digest and sequencing, 
the fragments were cloned into the respective restriction sites of the pGK12 
vector. 
The long arm of homology containing the exons 4 to 6 was PCR 
amplified from C57BL/6J BAC DNA via PCR using the oligonucleotides 
P_long1_5 and P_long6_3, adding restriction sites for FseI and XhoI to the 
amplified fragment, which was then processed as described above and cloned 
into the pGK12 vector containing the short arm of homology.  
For verification of correct clones an additional control digest was 
performed, and homology arms were sequenced. The sequences of used 
oligonucleotides are depicted in table 2.2. 
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Prior to electroporation of murine V6.5 ES (129Sv x C57BL/6) cells, 30 
µg of vector DNA was linearized with NotI. Successfully electroporated ES cells 
were double selected with G418 and ganciclovir. After selection, 300 clones 
were isolated as single, undifferentiated colonies and grown for 3 days. All 
clones were analysed by Southern Blot analysis or partly used for freezing at -
80°C. 
The probes used for Southern Blot analysis were PCR amplified from 
mouse DNA using the primers SB5A and B (probe A), and Neo5 and 3 (probe 
B). BamHI digestion of the genomic DNA derived from the selected clones and 
hybridization of probe A was used to determine 5´integration of correctly 
targeted clones. BglI digest and hybridization of probe B verified single and 
correct 3´integration of the construct. Out of 300 clones, one homologous 
recombinant that showed successful insertion of the neo cassette in exon 2 of 
the PLRG-1 gene could be detected. Hybridization with probe A yielded a 
recombinant band of 2.6 kb in addition to the 7.8 kb wild type band. Using probe 
B, a specific band of 9 kb was visible, confirming the homologous recombination 
(Fig 3.2B).  
Homologous recombinant ES cells were injected into C57BL/6 
blastocysts, which subsequently were transferred into a pseudo-pregnant foster 
mouse. Resulting 80-90% chimeric mice were crossed to C57BL/6 mice in order 
to receive PLRG-1∆/+ mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results   
46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 Analysis of PLRG-1∆/+ mice 
 
 PLRG-1∆/+ mice were viable and did not exhibit any significant differences 
in size or body weight (Fig 3.3A). The slighly elevated weight of PLRG-1∆/+ 
females was attributed to the mixed background of this mouse strain. Western 
Blot analysis of different mouse adult tissues revealed no difference in 
expression of PLRG-1 in all tested organs (Fig. 3.3B).  
 
Figure 3.2: Conventional inactivation of the PLRG-1 gene 
(A) Schematic representation of the PLRG-1 gene replacement vector and its respective 
localization within the murine PLRG-1 locus. 
(B) Verification of PLRG-1 gene replacement. Left panel: Southern blot analysis of ES cell 
clones hybridized with the probe A depicted in A. Right panel: Southern blot analysis of 
the same clones hybridized with probe B corresponding to the neomycin-resistance gene 
to verify single copy integration. 
WT stands for wild type and the respective band, RI for random integrant, HR for 
homologous recombinant and the respective band 
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3.4 PLRG-1∆/∆ mice are embryonic lethal 
 
 To generate PLRG-1∆/∆ mice, PLRG-1∆/+ mice were intercrossed. The 
first analysis of offspring at postnatal day 21 indicated the absence of PLRG-
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Figure 3.3: Analysis of PLRG-1∆/+ offspring 
(A) Body weight of PLRG-1∆/+ (n=14) and wild type males (n=10) 
(B) Body weight of PLRG-1∆/+ (n=18) and wild type females (n=16)  
(C) Expression analysis of PLRG-1 in PLRG-1∆/+ and wild type mice. Anti-AKT was used 
to control for loading. Open squares: wt; filled squares: PLRG-1∆/+   
WT WT WT WT WT WT
sc. muscle
W
AT
kidney
lung
spleen
heart
PLRG-1
AKT
∆/+ ∆/+ ∆/+ ∆/+ ∆/+ ∆/+
Results   
48 
1∆/∆ mice (Table 3.1). Due to this fact, the genotype of animals was monitored 
from birth, showing a lack of PLRG-1∆/∆ mice in all inspected litters (Tab.3.1). 
 In order to define the time point at which PLRG-1∆/∆ mice die, different 
embryonic stages were investigated, ranging from embryonic day (ED) 0.5 to 
18.5. Genotyping of embryos was performed using a semi-nested PCR enabling 
the amplification of DNA fragments from single cells. A three primer strategy in 
the first PCR was applied using oligonucleotides in front of exon 2 (W5.1), 3´ of 
exon 2 (W3.2) and 5´ of the neomycine resistance cassette (1.2 rev1) (Fig. 
3.4A). The PCR product was divided to be used as a template in a second PCR 
reaction, in order to detect the wild type allele and the deleted PLRG-1 allele. 
Both PCR reactions depend on the same antisense oligonucleotides, whereas 
the sense oligonucleotide of the second PCR was designed to anneal 70bp 
downstream of exon 2 (W5.2) (Fig. 3.4A). This method enabled the 
identification of different genotypes (Fig. 3.4B).  
Detailed inspection of litters at these different stages of embryogenesis 
revealed that homozygous PLRG-1-deficient embryos were viable until 
embryonic day 1.5 (Table 3.1 and Fig. 3.4B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1: Genotype analysis of PLRG-1∆/+-intercross offspring based on a semi-
nested PCR approach 
PLRG-1∆/+ x PLRG-1∆/+ +/+ ∆/+ ∆/∆ Total
E 0.5 3 11 3 17
E1.5 6 15 9 30
E2.5 3 10 0 13
E3.5 11 15 0 26
E12.5 3 15 0 18
E18.5 15 32 0 47
P21 33 58 0 91
Homozygous PLRG-1-deficient early embryos are only detectable up to embryonic 
day (ED) 1.5. 
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Although I could identify PLRG-1-deficient embryos up to ED 1.5, microscopical 
inspection revealed their substantial degradation (Fig. 3.5). In contrast, wild type 
embryos exhibited a normal two-cell stage morphogenesis at ED 1.5 (Fig. 3.5).  
These results indicate that PLRG-1 plays a crucial role during early 
embryogenesis at the stage of the first cell division. 
 
 
 
Figure 3.4: Identification of genotype using semi-nested PCR 
(A) Schematic representation of semi-nested PCR strategy.  
(B) Semi-nested PCR of ED 1.5 old embryos displaying all possible combinations of 
genotypes, such as wild type, ∆/+ (PLRG-1∆/+) and KO (PLRG-1∆/ ∆) 
∆ stands for the deleted allele 
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3.5 Generation of a conditional PLRG-1 gene replacement vector 
 
As embryonic death of PLRG-1-deficient embryos does not permit any 
further analysis, I decided to inactivate the PLRG-1 gene conditionally. The 
targeting vector introduced loxP sites upstream and downstream of exon 3, and 
deletion of exon 3 by Cre-mediated recombination was predicted to cause a 
frame-shift mutation resulting in a translational stop after 59 amino acids (Fig. 
3.6A).  
The pGK12 vector was used and the cloning steps were performed as 
described for the conventional targeting strategy. To introduce the 2.5 kb short 
arm of homology consisting of exon 1, intron 1 and the first 27 bp of exon 2 
amplified from C57BL/6 BAC DNA via PCR. For this purpose the primers KA5 
and KA3 were used containing restriction sites for NotI and SacII, respectively. 
For amplification of the loxP-flanked exon 3, oligonucleotides flExon3_5 and 
flExon3_3 harbouring AscI and FseI restriction sites were used. The fragment 
was digested with the respective restriction enzymes and cloned into the pGK12 
vector already containing the short arm of homology. The 5 kb long arm of 
homology consisting of a 5 kb fragment including genomic DNA from exons 4 to 
6 was PCR-amplified with the primers LA5 and LA3, containing restriction sites 
for XhoI and PmeI. The long arm of homology was introduced with the 
Figure 3.5: Representative morphology of wild type and PLRG-1-deficient embryos 
at ED1.5 
Wild type embryos show normal two-cell stadium, whereas knockout embryos are 
degenerated, showing failed division and fragmented nuclei. Shown are representative 
pictures of 9 embryos of each genotype analyzed.  
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respective restriction enzymes into the pGK12 vector already containing the 
short arm of homology and the loxP-flanked exon 3. The sequences of used 
oligonucleotides are depicted in table 2.1. All PCR products were subcloned 
and verified by sequencing and restriction digest analysis. V6.5 (129Sv x 
C57BL/6) ES cells were electroporated with 30 µg of NotI linearized targeting 
vector and double selected with G418 and ganciclovir (as described in materials 
and methods). 450 clones were isolated and analyzed by Southern Blot using 
the same probes described for the conventional targeting vector (Fig. 3.6A and 
B). Probe A was used to determine 5´integration of correctly targeted clones 
after BamHI digestion, resulting in a recombinant band of 4.4 kb besides the 7.8 
kb wild type band. BglI digest and use of probe B verified single and 
3´integration of the construct through a 5.8 kb band. To confirm the 
cointegration of the external 3´loxP site, a PCR was performed using 
oligonucleotides Lox5 and Lox3 (Fig. 3.6C). Four homologous recombinant 
clones containing the external loxP site could be identified. Injection of one 
homologous ES cell clone into BL/6 blastocysts yielded in high-grade chimeras 
transmitting the conditional PLRG-1 allele (PLRG-1flox/+) through germline. 
Intercrosses of PLRG-1flox/+ mice generated PLRG-1flox/flox mice according to the 
expected Mendelian ratios. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results   
52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WT
HRWT
HR
7,8 kb
1 2
1 2 3
HR 5,8 kb
1 2 3
250bp
320bp
4.4 kb
Figure 3.6: Conditional inactivation of the PLRG-1 gene 
(A) Schematic representation of the targeting strategy to introduce loxP sites (triangles) into 
the PLRG-1 locus.  
(B) Southern Blot analysis of ES cell clones after electroporation with the targeting construct 
shown in A. Blots were hybridized with the probes depicted in A. Upper panel: Homologous 
recombinant (1) displaying a 4.4kb band beside the 7.8kb wild type band using a BamHI 
digest and probe A specific for PLRG-1. Lower panel: The 5.8 kb band indicates single 
integration of the targeting vactor using BamHI digested DNA and probe B hybridizing to the 
neomycin resistance gene (1). 
(C) PCR analysis with primers flanking the 3’-loxP site confirming co-integration of this loxP 
site. The 250bp band indicates the wild type (wt) locus, whereas the 320bp band displays the 
correct integration of the external loxP site (1 and 3). 
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3.6 Inactivation of PLRG-1 in mouse embryonic fibroblasts blocks cell 
proliferation  
 
 For in vitro experiments, mouse embryonic fibroblasts (MEF) from wild 
type and PLRG-1flox/flox embryos were generated and treated with recombinant, 
cell permeable Cre protein (HTNC) (Peitz et al., 2002). Cre-treatment resulted 
in efficient removal of exon 3 from the PLRG-1flox/flox locus as verified by PCR 
using oligonucleotides LA2 and Seq4, yielding a 1.7 kb band for wild type and a 
1 kb band for PLRG-1flox/flox MEF treated with HTNC (Fig. 3.7A and B). MEFs 
carrying the resulting PLRG-1 mutant locus lacked detectable PLRG-1 protein 
expression as verified by Western Blot analysis (Fig. 3.7C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Verification of PLRG-1 deletion in MEFs upon HTNC treatment 
(A) Schematic representation of PCR primer locations 
(B) PCR analysis of wild-type (lanes 1 and 2) and PLRG-1flox/flox MEF (lane 3, ∆) after 
treatment with cell permeable Cre-protein using primers LA2 and Seq 4.  
(C) Western Blot analysis of wild type (lane 1) and PLRG-1flox/flox MEFs (lane 2) after 
HTNC treatment. 
A 
B 
C 
WT∆
PLRG-1
1 2
1 2 3
unspecific
Results   
54 
 As the conventional PLRG-1 knockout in mice resulted in a defect in cell 
division during embryogenesis, the growth rate of wild type and PLRG-1flox/flox 
MEFs was determined in the absence or presence of HTNC treatment. Cells 
were incubated overnight in serum free DMEM with or without HTNC, thereafter 
re-exposed to medium supplemented with fetal calf serum and were counted 
every day using a Neubauer Hemocytometer.  
Cre-treatment of PLRG-1flox/flox MEFs resulted in an immediate growth 
arrest of these cells, while having no effect on wild type MEF proliferation 
compared to untreated wild type and PLRG-1flox/flox MEFs (Fig. 3.8A).Also, 
PLRG-1-deficiency in MEFs resulted in a larger cell size, potentially due to a 
block in G0/G1- or in G2/M-phase (Fig. 3.8B).  
This phenotype is similar to the phenotype observed in conventional 
PLRG-1 knockout mice, in which the PLRG-1 mutation resulted in a failure to 
execute the first cell division during embryogenesis, emphasizing the 
assumption that PLRG-1 is essential for cell proliferation. 
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3.7 PLRG-1 deficiency prevents S-phase entry 
 
 To define the precise role of PLRG-1 during cell proliferation, analysis of 
serum stimulated cell cycle progression in wild type and PLRG-1-deficient 
MEFs by fluorescence activated cell sorting (FACS) was performed. Using 
propidiumiodide (PI) as an intercalating dye for DNA, it is possible to distinguish 
between G0/G1-, S- and G2/M-phase. The first peak in a FACS histogram 
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Figure 3.8: Growth rates and morphology of untreated or Cre-treated wild type and 
PLRG-1flox/flox MEFs 
(A) Circles: WT MEFs; squares: PLRG-1flox/flox MEFs; open symbols: -Cre; closed symbols: 
+Cre. Data represent mean + SEM of three independent experiments, each performed in 
duplicate  
(B) MEFs were treated with cell-permeable HTN-Cre and microphotographed after 48h 
incubation. 
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represents the G0/G1-phase, in which cells contain the normal 2n DNA content 
The following S-Phase is relatively short with a duration of approximately 2 to 4 
hours. It contains an intermediate DNA content and is depicted in a histogram 
as the phase between the two peaks. The second peak displays the G2/M-
phase, which is characterized by the double 4n DNA content after S-phase and 
is the last phase before entering mitosis and cytokinesis. Here again cells grow 
until they receive the signal to progress into mitosis. To perform this experiment, 
cells have to be synchronized by serum depletion for 24 – 48 h resulting in 
resting cells in G0/G1 phase. After addition of serum, cells will progress 
simultaneously into cell cycle allowing the distinction between the different cell 
cycle phases.  
 While serum stimulation resulted in G1- to S-phase progression in wild 
type cells in both absence and presence of recombinant Cre protein, the S-
phase entry was blocked in PLRG-1flox/flox MEF after HTNC treatment (Fig. 3.9). 
45.7%46.3%45.2%35.3%G2/M-Phase
3.2%2.3%5%2.3%S-Phase
51.1%51.4%49.8%62.4%G1/G0-Phase
KO+FCSKO-FCSWT +FCSWT -FCS
 
 
 
 
 
 
Figure 3.9: FACS analysis of serum (FCS)-stimulated cell cycle progression in control 
and PLRG-1-deficient MEFs 
Different cell cycle phases of wild-type and PLRG-1-deficient MEFs before serum 
stimulation (-FCS: left) and 24 h after serum stimulation (+FCS: right). Distribution of cell 
cycle phases obtained from three independent experiments are summarized in the table. 
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 To confirm the observed block in cell cycle as revealed by FACS 
analysis, a 3H-thymidine incorporation assay was performed. This method 
determines the ability to replicate DNA by measuring the incorporation of 3H-
thymidine into newly synthesized DNA. Therefore, cells were again 
synchronized by serum deprivation to start in the G0/G1-phase and were then 
stimulated with 10% FCS to initiate cell cycle progression. The 3H-thymidine 
content of wild type and PLRG-1flox/flox MEFs treated with HTNC protein was 
measured at 0, 16 and 24 h after FCS stimulation. PLRG-1-deficient MEFs did 
not incorporate 3H-thymidine at any time point, which confirmed the disability to 
progress into the S-phase (Fig. 3.10), demonstrating that PLRG-1 is required for 
serum-stimulated G1/S-phase transition in murine cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.8 PLRG-1 deficiency increases p53 expression and induces apoptosis  
 
 To investigate the molecular mechanism by which PLRG-1 ablation 
prevents cells from entering the S-phase, the early regulatory steps of G1/S 
transition were examined using biochemical approaches. Wild type and PLRG-
1flox/flox MEFs were treated with cell permeant Cre-protein to delete PLRG-1, 
serum deprived for 48 h to synchronize MEFs in G0/G1-phase and subsequently 
stimulated with 10% FCS to progress into cell cycle. Cells were harvested, 
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Figure 3.10: 3H-thymidine incorporation of wild type and PLRG-1-deficient MEFs 
3H-thymidine incorporation was measured after 0, 16, and 24 h of serum stimulation in wild-
type (open bars) and PLRG-1-deficient (closed bars) MEFs. Values represent mean + SEM 
values from three independent experiments (∗p < 0.05). 
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lysed and cellular proteins were seperated by SDS-PAGE, transferred onto 
PVDF membranes to determine expression and phosphorylation of proteins 
responsible for G1/S-phase progression, such as Erk1 and Erk2 MAP kinases, 
which are key mediators of proliferative signalling by Western Blot analysis. In 
addition, proteins, which are expressed as a result of Erk1 or Erk2 activation, 
such as Cyclin D1 and Cyclin E, were also analyzed.  
During G1- to S-phase progression, Cyclin D1 binds CDK4 and allows for 
the hyperphosphorylation of Retinoblastoma (Rb) protein, leading to a release 
of the transcription factor E2F. E2F is responsible for transcription of proteins 
involved in DNA replication and cell cycle progression, such as MCM proteins 
and Cyclin E. Cyclin E, in turn, activates more CyclinD1/CDK4 complexes, 
thereby promoting the G1-S-phase progression.  
Expression and activation status of other proteins involved in a G1/S-
phase block, namely p53, stabilized S15-phosphorylated p53 and CDK inhibitor 
p21, were also determined. 
 Examination of the regulatory steps of G1/S transition revealed an 
unaltered biphasic activation of MAP kinases Erk1 and Erk2 in both wild type 
and PLRG-1-deficient MEFs upon serum stimulation (Fig. 3.11) (Balmanno and 
Cook, 1999). In contrast, serum stimulated Cyclin D1 expression was 
dramatically reduced in PLRG-1-deficient MEFs compared to wild type cells 
(Fig. 3.11). The mutant cells also displayed significantly lower Cyclin E 
expression (Fig. 3.11). Concomitantly, expression of p53, and also, during later 
time points of serum stimulation, of CDK inhibitor p21 were increased in the 
absence of PLRG-1 (Fig. 3.11). 
 The activity of p53 is tightly controlled via posttranslational modification, 
in particular through stabilization by phosphorylation (Nakagawa et al., 1999; 
She et al., 2000; Vega et al., 2004). Therefore, the phosphorylation state of p53 
was analyzed by immunoblotting using an antibody recognizing phosphorylated 
p53 at serine 15. During the course of serum stimulation, remarkably higher 
levels of p53 phosphorylation at serine 15 were observed in PLRG-1-deficient 
cells compared to wild type cells (Fig. 3.11). Taken together, the elevated levels 
of phosphorylated p53 protein correlate with the block of S-phase transition and 
the increase of CDK-inhibitor p21 levels in MEF cells lacking PLRG-1. 
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 Since continuously elevated p53 levels are known to induce apoptosis 
(M. Schuler, 1997), I directly addressed whether apoptosis is increased in 
PLRG-1-deficient MEFs. Therefore, TUNEL assays were performed, which 
revealed a dramatic induction of apoptosis in PLRG-1-deficient MEFs compared 
to wild type controls (Fig. 3.12). PLRG-1-deficient MEFs exhibited 
approximately 7%, whereas wild type cells displayed 0.5% of apoptotic cells 
(Fig. 3.12). 
 To further characterize p53-induced apoptosis, expression of p53 targets 
and downstream effectors of apoptosis was determined. Caspase 3, an 
aspartate-specific cysteine protease, is a key executor of apoptosis and is 
typically activated by proteolytic processing. It triggers apoptosis by cleavage of 
different cytosolic and nuclear substrates, such as poly (ADP-ribose) 
polymerase (PARP) and ICAD. Consistent with the detection of enhanced 
apoptosis, cleavage of caspase 3 was also dramatically increased, as assessed 
by Western Blot (Fig. 3.12). This was paralleled by increased levels of the pro-
apoptotic Bax protein, its gene being a well-characterized target of p53, along 
with a slight decrease in the level of anti-apoptotic Bcl-2-protein in PLRG-1-
deficient MEFs (Fig. 3.12). 
In summary, these experiments indicate that PLRG-1 deficiency blocks 
G1/S-phase transition and stimulates apoptosis, possibly as a consequence of 
increased p53 phosphorylation and stabilization 
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Figure 3.11: Western blot 
analysis of HTNC-treated 
wild type (WT) and PLRG-
1flox/flox MEF (KO) 
HTNC-treated control and 
PLRG-1flox/flox-fibroblasts were 
serum deprived for 48 h and 
then stimulated with 10% FCS 
for 2, 4, 6, 8 h, respectively. 
Expression of MAPK, Cyclin 
D1, Cyclin E, p53, and p21 as 
well as phosphorylation of 
MAPK and S-15 
phosphorylation of p53 were 
analyzed by western blot. Anti-
β-actin served as a loading 
control.  
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3.9 No evidence for altered splicing in PLRG1-deficient MEFs  
 
As PLRG-1 has been initially identified as a component of the 
spliceosome and as peptides interfering with the PLRG-1/CDC5L interaction 
inhibit pre-mRNA-splicing in vitro, the question was addressed, whether PLRG-
1 deletion results in pre-mRNA accumulation and a reduction of mRNA. 
Therefore, RNA from untreated and HTNC-treated PLRG-1flox/flox MEFs was 
isolated 48 h after Cre-treatment. RNA was DnaseI digested and used for RT 
PCR. Following, PCR using exon spanning primers for Cyclin D1 (5CycD1, 
3CycD1), Cyclin E1 (5CycE1, 3 CycE1) and p53 (p53-5RT, p53-3RT) were 
performed, to investigate splicing defects of these genes. DNA was used as 
positive control for detectability of unspliced products, i.e. pre-mRNA. PLRG-1-
deficient MEFs did not show aberrant splicing of these genes displaying correct 
spliced products as observed in untreated PLRG-1flox/flox MEFs (Fig 3.13 A and 
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Figure 3.12: TUNEL analysis of wild type and PLRG-1-deficient MEFs 
Upper panel: Photomicrograph of TUNEL-stained wild type and PLRG-1-deficient MEFs. 
TUNEL-positive cells are marked by white arrows. Lower left panel: Percentage of apoptotic 
cells in wild type and PLRG-1-deficient MEFs. Values represent mean + SEM from three 
independent experiments (∗∗∗p < 0.001). Lower right panel: Expression of Bax, Bcl-2, and 
active cleaved Caspase 3 of wild type and PLRG-1-deficient MEFs. Anti-β-actin was used to 
control for equal loading. 
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B). Thereby, reduced Cyclin D1 and E1 expression in PLRG1-deficient MEFs 
shown in serum stimulated cell cycle progression was not due to aberrant 
splicing of these genes. 
For further validation quantitative Real-time PCR was performed using 
probes for genes involved in ER stress (Ddit 3), transcriptional and cell cycle 
regulation (Foxo 1, Foxo 3a), Notch signalling (Notch 1), inflammation (TGF-β1) 
and cytoskeletal formation (Tuba 1). No difference in expression of these genes 
was observed, except for α-tubulin, which was 1.5 fold increased in PLRG-1-
deficient MEFs (Fig. 3.13 C). This was consistent with the findings in PLRG-1-
deficient MEFs, which display an increased cell size 
 
 
 
Cyc D1
Cyc E1
p53
C KO DNA
Flox
∆
C KO
0
20
40
60
80
100
120
140
160
180
200
%
 o
f c
on
tr
ol
Ddit 3 Foxo 1 Foxo 3a Notch 1 TGF-β1 Tuba 1
*
%
 o
f c
on
tr
ol
%
 o
f c
on
tr
ol
 
 
 
 
Taken together, these results indicate, that PLRG1-deficient MEFs did 
not suffer from general alteration in pre-mRNA-splicing, as proposed for yeast 
or mammals using an adeno-pre-mRNA vector for splicing assays. 
Figure 3.13: Splicing in PLRG-1-deficient MEFs is unaltered 
(A) PCR analysis of untreated (C) and HTNC treated PLRG-1flox/flox MEF (KO) using primers 
lox3 and lox5 for the loxP flanked allele and LA2 and Seq 4 for the deleted allele 
(B) PCR analysis based on cDNA and exon spanning primers. Control and KO samples 
show no aberrant splicing. DNA represents the unspliced variant of Cylin D1, Cyclin E1 and 
p53 
(C) Expression analysis of PLRG-1flox/flox (open bars) and PLRG-1-deficient (closed bars) 
MEFs of Ddit 3, Foxo 1, Foxo 3a, Notch 1, TGF-β1 and Tuba 1 using quantitative Real-time 
PCR. Samples were adjusted for total RNA content by TBP RNA quantitative PCR 
Flox stands for PCR product of the loxP flanked allele, ∆ for PCR product of the deleted 
allele. 
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3.10 PLRG-1-deficient MEFs exhibit no spontaneously detectable DNA 
double-strand breaks 
 
Since p53 phosphorylation and accumulation represents a response to 
DNA damage and as it was recently demonstrated, that PLRG-1 is a 
component of the Pso4-complex, which uncouples DNA interstrand crosslinks, 
thus ensuring genomic integrity, I next directly addressed whether PLRG-1 
deficiency results in spontaneously detectable DNA double-strand breaks.  
Therefore, PLRG-1flox/flox MEFs left untreated or treated with cell 
permeable Cre. 48 h after HTNC treatment, MEFs left either unirradiated or 
were UV irradiated for 2 min to induce genomic instability, namely DNA double-
strand breaks. 24 h after UV-irradiation, cells were harvested, agarose 
embedded, lysed and used for pulse-field gel electrophoresis. Fragmented DNA 
was released into the gel and visualized using EtBr staining, whereas 
highmolecular and unfragmented DNA remained in the agarose plugs. 
Untreated and HTNC-treated MEFs showed no difference in DNA release into 
the gel, indicating that PLRG-1 deficiency per se did not cause DNA double-
strand breaks, whereas UV-irradiated cells displayed DNA fragmentation, 
resulting in DNA release into the pulse-field gel to similar extend in PLRG-
1flox/flox and deficient MEFs (Fig. 3.14). 
KOC KOC
-UV +UV
 
Figure 3.14: Pulse-field gel 
electrophoresis of PLRG-1flox/flox 
(control) and PLRG-1-deficient 
MEFs (KO)  
PLRG-1flox/flox MEFs left untreated 
or treated with HTNC. As control 
for DNA fragmentation, cells were 
UV treated. The gel shows two 
control versus two KO samples. 
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In summary, these experiments indicate that PLRG-1 deficiency does not 
enhance genomic instability, by promoting occurrence of spontaneous DNA 
double-strand breaks. 
 
 
3.11 PLRG-1 deficiency results in enhanced γ-H2AX phosphorylation 
 
As a consequence of stalled replication forks or DNA double-strand 
breaks spontaneously occurring during DNA replication, the phosphorylation of 
γ-H2AX was investigated using immunofluorescence. γ-H2AX represents a 
variant of histone proteins, which are phosphorylated by members of the PIKK-
family, such as ATM and ATR, thereby recruited to stalled replication forks or 
DNA lesions.  
Therefore PLRG-1-deficient MEFs were investigated in terms of γ-H2AX 
phosphorylation. PLRG-1flox/flox MEFs left untreated or treated with cell permeant 
Cre protein. 48 h after HTNC treatment, cells were fixed and stained with 
phospho-S139-γ-H2AX antibody. PLRG-1-deficient MEFs showed enhanced γ-
H2AX phosphorylation compared to untreated PLRG-1flox/flox MEFs displaying an 
increase in γ-H2AX foci (Fig. 3.15A). About 90% of PLRG-1-deficient MEFs 
were γ-H2AX positive compared to 10% of untreated MEFs (Fig. 3.15B) These 
data indicate that PLRG-1 deficiency results in increment of γ-H2AX foci as a 
result of stalled replication forks, rather than DNA double-strand breaks as 
shown in figure 3.14 using PFGE.  
 
 
 
 
Figure 3.15: Analysis of γ-H2AX phosphorylation in untreated and HTNC-treated PLRG-
1flox/flox MEFs 
(A) Photomicrograph of phospho-S139-γ-H2AX -stained PLRG-1flox/flox (Control) and PLRG-1-
deficient MEFs (KO). Representatitve S139-γ-H2AX-positive cells are marked by white arrows. 
(B) Percentage of γ-H2AX positive cells in control and PLRG-1-deficient MEFs. Values 
represent mean + SEM from three independent experiments (∗∗∗p < 0.001) 
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3.12 Conditional inactivation of PLRG-1 in heart and skeletal muscle  
 
To examine developmental regulatory effects of PLRG-1 in vivo, mice 
with conditional tissue-specific inactivation of the PLRG-1 gene were generated. 
To obtain mice lacking PLRG-1 specifically in skeletal muscle and heart, PLRG-
1flox/+ mice were crossed with mice expressing the Cre recombinase under the 
control of the muscle-specific creatinine kinase (MCK) promoter (Brüning et al., 
1998). Double-heterozygous PLRG-1flox/+MCKCre mice were crossed with 
PLRG-1flox/flox mice to obtain PLRG-1flox/floxMCKCre offspring lacking PLRG-1 
expression in skeletal muscle and heart (PLRG-1∆mus). As in the case of 
conventional PLRG-1-deficient knockout mice, the analysis of offspring from 
these breedings at postnatal day 28 revealed the absence of PLRG-1∆mus mice, 
indicating that PLRG-1 deficiency also in skeletal muscle and heart results in 
early lethality (Table 3.2). 
 
 
 
 
 However, in contrast to the conventional knockout mice, PLRG-1∆mus 
mice were detected at the expected Mendelian frequency at birth (Table 3.2) 
leading to the assumption that during early lifespan a defect in heart and 
skeletal muscle occurs due to PLRG-1 defiency. To confirm heart- and muscle-
specific recombination of the PLRG-1 gene in PLRG-1∆mus mice, genomic DNA 
was extracted from individual tissues of PLRG-1flox/flox and PLRG-1∆mus mice at 
postnatal day 5 and subjected to PCR analysis using the oligonucleotides LA2 
and Seq4 as shown in figure 3.7. Surprisingly, only in heart successful 
recombination could be detected (Figure 3.16). Presumably, expression and 
activity of MCKCre in skeletal muscle is initiated during later stages of murine 
development. Deletion efficiency in heart was not 100%, as can be concluded 
Table 3.2: Genotype analysis of mice obtained from breedings of PLRG-1flox/flox mice 
with PLRG-1flox/+MCKCre mice 
PLRG-1 flox/+ PLRG-1 flox/flox PLRG-1 flox/+ MCKCre PLRG-1 Total
P1 18 16 28 20 82
P28 10 19 16 0 45
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from the appearance of a PCR product for the floxed allele besides the band for 
the deleted allele. It is possible that full Cre expression and activity in heart 
cannot be reached before failure of the organ. 
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C KO
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∆ 1kb
 
 
 
 
 
 
 Close postnatal monitoring of the litters revealed that, while 80% of 
control mice survived the first 28 days of life, the survival rate of PLRG-1∆mus 
mice was dramatically reduced to 5% during the same period (Fig. 3.17). The 
premature death of control animals displays normal values for animals kept 
under standard animal care in the animal facility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: Heart-restricted PLRG-1 deficiency in PLRG-1∆mus mice 
PCR analysis of genomic DNA isolated from different organs of 5d old PLRG-1flox/flox and 
PLRG-1∆mus mice. The panel shows the specific deletion of PLRG-1 in the heart using 
primers flanking exon 3. Excision of exon 3 is indicated by PCR amplification of a 1 kb 
DNA fragment (∆). PCR analysis with primers flanking the 3´-loxP site was used as 
loading control (Flox) (1: brain, 2: skeletal muscle, 3: heart, 4: liver, 5: spleen). 
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Figure 3.17: Survival rate of 
control and PLRG-1∆mus mice 
Survival rate of control (closed 
circles) and PLRG-1∆mus (open 
circles) mice (n = 40 control 
(PLRG-1flox/flox, PLRG-1flox/+ and 
wild type), n = 14 PLRG-1∆mus). 
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3.13 Conditional inactivation of PLRG-1 in heart results in dilated 
cardiomyopathy due to increased cardiomyocyte apoptosis 
 
 Because Cre-mediated recombination was only detectable in heart, heart 
function in mice surviving up to postnatal days 24 to 26 was investigated. 
Opening of the thorax revealed an increase in heart size in PLRG-1∆mus mice 
(Fig 3.18A) Consistent with this observation, quantitative assessment of heart 
mass revealed an increase in heart weight of PLRG-1∆mus mutant compared to 
control mice (PLRG-1flox/flox) (Fig. 3.18B) 
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 Haematoxylin / Eosin staining and histological analysis of hearts at 
postnatal day 24 demonstrated severe thinning of both ventricle walls and 
Figure 3.18: Heart-phenotype of PLRG-1∆mus mice 
(A) Autopsy of postnatal day 24 control (PLRG-1flox/flox) and PLRG-1∆mus (KO) mice. Note the 
enlarged heart for PLRG-1∆mus compared to control. 
(B) Relative heart/body weight ratio in control and PLRG-1∆mus mice. Data represent the 
mean ± SEM of seven control and six PLRG-1∆mus mice (∗∗∗p < 0.001). 
A 
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massive dilatation of both left and right ventricle in hearts derived from PLRG-
1∆mus, reflecting the pathology of severe dilated cardiomyopathy (Fig. 3.19). 
 Taking into account the results obtained from the analysis of PLRG-1-
deficient MEFs, the question arose, whether the heart dilation was due to 
increased apoptosis of cardiomyocytes. In fact, TUNEL staining of explanted 
heart tissue revealed an increase in apoptotic cardiomyocytes in the PLRG-
1∆mus mice compared to control mice (Fig. 3.19). 
Control KO
 
 
 
 
 
 
 Western blot analysis of protein extracts from hearts of control and 
PLRG-1∆mus mice showed increased Bax and decreased Bcl-2 expression (Fig. 
3.20). Consistent with the previous findings in PLRG-1-deficient MEFs, hearts of 
PLRG-1∆mus mice also showed higher levels of phosphorylated p53 (Fig. 3.20). 
Taken together, these results establish the underlying molecular basis of PLRG-
1∆mus pathology, which is characterized by dilated cardiomyopathy due to 
increased cardiomyocyte apoptosis in the presence of enhanced p53 
phosophorylation along with increased Bax and decreased Bcl-2 expression. 
The data also demonstrate that the PLRG-1-dependent pathway regulating 
Figure 3.19: Histological analysis of control- and PLRG-1∆mus-hearts at the age 
of 24 days 
The upper panel shows H&E stained control and PLRG-1∆mus hearts. The lower panel 
shows TUNEL stained heart sections, revealing increased cardiomyocyte apoptosis in 
PLRG-1∆mus hearts.  
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apoptosis, as determined for PLRG-1-deficient MEFs, is also functional in 
tissues of postnatal mice. 
 
 
 
 
 
 
 
 
 
 
 
3.14 Conditional inactivation of PLRG-1 in the central nervous system of 
mice results in early postnatal lethality  
 
 To investigate whether the observed phenotype of PLRG-1 deficiency 
represents a more general phenomenon, PLRG-1 was also inactivated in 
another predicted non-mitotic organ, i.e. the post-mitotic neurons in the central 
nervous system (CNS), by intercrossing PLRG-1flox/flox mice with mice 
expressing the Cre recombinase under control of the Synapsin promoter (Zhu et 
al., 2001). The Cre transgene was always transferred maternally due to an 
undesired germline activity in males (Rempe et al., 2006). PLRG-1flox/flox mice 
were crossed with PLRG-1flox/+SynCre mice to obtain PLRG-1∆CNS mice with 
neuron-restricted PLRG-1 deficiency. These mice also revealed early lethality 
as no PLRG-1∆CNS mice reached the age of weaning (Table 3.3). 
 Table 3.3: Genotype analysis of mice obtained from breedings of PLRG-1flox/flox mice 
with PLRG-1flox/+SynCre mice 
Figure 3.20: Western blot analysis of control (C) and PLRG-1∆mus-(KO) hearts 
Expression of total cellular protein extracts of p53, S15-phopho-p53 (pp53), Bcl-2 and Bax 
was analyzed by western blotting. Anti-AKT was used to control for equal loading. 
PLRG-1 flox/+ PLRG-1 flox/flox PLRG-1 flox/+ SynCre PLRG-1 Total
P1 11 13 18 13 55
P21 8 8 13 0 29
AKT
p53
pp53
Bcl-2
Bax
KOC
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 Monitoring of the litters directly after birth showed an even more dramatic 
phenotype of PLRG-1∆CNS mice than PLRG-1∆mus mice. PLRG-1∆CNS mice had 
survival rates of only 25% at postnatal day 3, while control mice showed an 
88% survival rate, representing normal surviving variations of mouse 
populations in standard animal facilities. On postnatal day 9 no surviving PLRG-
1∆CNS mice were observed, indicating again the important role PLRG-1 plays in 
the developing mouse (Fig. 3.21). 
 PCR analysis of genomic DNA derived from 3 day old control and PLRG-
1∆CNS mice at postnatal day 3 using oligonucleotides LA2 and Seq4, confirmed 
CNS-restricted recombination of the PLRG-1 gene in PLRG-1∆CNS mice (Fig. 
3.22). Again, deletion was not complete, since full Cre expression and activity 
would require longer survival. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.15 Neuron-restricted PLRG-1 deficiency results in massive neuronal 
apoptosis 
 
Figure 3.21: Survival rate of control and PLRG-1∆CNS mice 
Survival rate of control (n = 25 (PLRG-1flox/flox, PLRG-1flox/+ and wild type)) and PLRG-1∆CNS (n = 
12) mice at days 1, 3, and 9.  
Figure 3.22: Analysis of neuron-restricted recombination of the PLRG-1flox/flox allele 
The panel shows specific deletion of PLRG-1 in the brain of PLRG-1∆CNS mice (KO). Using a 
primer pair flanking exon 3, the appearance of a product of 1 kb indicated excision of exon 3 
(∆). PCR analysis with primers flanking the 3´-loxP site was used as loading control (Flox) (1: 
brain, 2: skeletal muscle, 3: heart, 4: liver, 5: spleen). C stands for PLRG-1flox/flox mice (control) 
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 As PLRG-1 deficiency induced apoptosis in both MEFs and heart tissue, 
I also examined the occurrence of apoptosis in the CNS of control and PLRG-
1∆CNS mice. Brains from control (PLRG-1flox/flox) and PLRG-1∆CNS mice at 
postnatal day 3 were dissected and used for TUNEL analysis. Investigation of 
control and PLRG-1∆CNS mice revealed a dramatic increase in the number of 
apoptotic neurons in the dentate gyrus of PLRG-1∆CNS mice, coinciding with the 
region where Synapsin Cre mice have been shown to recombine most 
efficiently and where neurogenesis takes place (Fig 3.23) (Zhu et al., 2001). 
PLRG-1∆CNS mice showed reduced agility, trembled and were not able to roll 
over when turned on their back.  
 
 
 
 
 
 
 
 
 
 
 
 
 As in PLRG-1-deficient MEFs and PLRG-1∆mus mice, Western Blot 
analysis of brain tissue revealed increased p53 expression levels as well as 
enhanced p53 serine 15-phosphorylation in PLRG-1∆CNS mice. Bax levels 
remained unaltered in brain cells, whereas PLRG-1∆CNS mice also displayed a 
decrease in Bcl-2 expression (Fig. 3.24).  
 
Figure 3.23: 
Immunohistochemical 
analysis of brains 
dissected from 3-day-
old control and PLRG-
1∆CNS mice 
Left and right panels: 
DAPI (nucleus) and 
TUNEL staining for 
control and KO of the 
same brain sections. 
Control
KO
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 In summary, the absence of PLRG-1 in the CNS leads to massive 
apoptosis in the hippocampus. Thus, deficiency of PLRG-1 in the CNS evokes a 
similar apoptotic response to that observed in PLRG-1-deficient MEFs or 
cardiomyocytes. 
 
 
3.16 Interaction of the nuclear CDC5L-PLRG-1 complex with the p53 
phosphatase WIP1 is disrupted in the absence of PLRG-1 
 
 The previous studies with heart- and neuron-specific PLRG-1 knockout 
mice revealed massive apoptosis in the respective tissues, responsible for the 
premature death of the animals. Moreover, PLRG-1-deficient MEFs failed to 
enter S-phase upon serum stimulation and showed increased apoptosis as a 
result of enhanced p53 phosphorylation and stabilization. To understand the 
molecular basis of the PLRG-1 deficiency phenotype, the connection between 
PLRG-1 and p53 was further investigated. 
 Mass spectrometry and affinity purification analyses of proteins 
associated with CDC5L, the known interaction partner of PLRG-1, identified 
numerous spliceosomal components including ASF/SF2, hnRNP-G, SAP145, 
and U2A, as well as protein phosphatases such as PP1, PP2, and WIP1. 
Taking this into account, the question was addressed whether the CDC5L-
PLRG-1 complex interacts with known p53 phosphatases, in particular with 
Figure 3.24: Western blot analysis of control (C) and PLRG-1∆CNS (KO) hearts 
Western blot analysis of total cellular protein extracts from control (WT) and PLRG-1mus-(KO) 
hearts showing expression of p53, S15-phopho-p53 (pp53), Bcl-2 and Bax. Anti-α-tubulin was 
used to control for equal loading. 
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WIP1. To this end, nuclear extracts of wild type MEFs were immunoprecipitated 
with anti-WIP1 or an unrelated control followed by Western Blot analysis with 
anti-CDC5L. This analysis revealed the presence of CDC5L protein in WIP1 
immunoprecipitates, but not in the unrelated controls (Fig. 3.25A), confirming 
the interaction of CDC5L and WIP1 in wild type control cells as previously 
reported (Ajuh 2000) 
 To determine whether the CDC5L-WIP1 interaction was also detectable 
in PLRG-1-deficient cells, co-immunoprecipitation experiments were performed 
using nuclear extracts from PLRG-1flox/flox MEFs 48 h after Cre treatment. 
Surprisingly, this analysis revealed no immunoreactive CDC5L in WIP1 
precipitates of PLRG-1-deficient nuclei (Fig. 3.25A). 
 To investigate whether this failure of CDC5L-binding to WIP1 is 
dependent on protein degradation or cytosolic translocation, CDC5L content 
was assessed in the respective fractions using Western Blot analysis. No 
difference in the total cellular content of CDC5L between wild type and PLRG-1-
deficient MEFs was observed, but strikingly, CDC5L could only be detected in 
the cytosol of PLRG-1-deficient cells, whereas in control cells, CDC5L was 
mainly located in the nucleus (Fig. 3.25B). These data indicate that CDC5L 
interacts with WIP1 in the nucleus and that this complex fails to form in the 
absence of PLRG-1, which presumably results in cytosolic relocalization of 
CDC5L. 
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3.17 Rescue of the apoptotic PLRG-1 phenotype by knockdown of p53 
 
 To address whether stabilization of the p53 protein functionally accounts 
for the phenotype resulting from PLRG-1 deficiency, the effect of a 
downregulated p53 expression in PLRG-1-deficient cells was investigated. 
MEFs were either left untransfected or were transfected with siRNAs directed 
either against an unrelated sequence, against PLRG-1, against p53 or against 
PLRG-1 and p53. In this approach, I chose to knock down PLRG-1 expression 
using siRNAs, because HTNC-mediated deletion of PLRG-1 followed by siRNA 
transfection is toxic for the cells. Western Blot analyses revealed efficient 
siRNA-mediated silencing of PLRG-1 and p53 (Fig. 3.26).  
Occurrence of apoptosis was determined performing TUNEL assays, and 
siRNA-mediated knockdown of PLRG-1 resulted in dramatically increased 
apoptosis in the presence of increased p53 expression and phosphorylation, as 
well as increased Bax and p21 expression, similar to the findings in PLRG-
Figure 3.25: CDC5L and WIP1 fail to form complexes in the nucleus of PLRG-1-
deficient MEFs 
(A) Control and PLRG-1flox/flox MEFs were treated with cell-permeable Cre protein overnight, 
lysed after 48 h, and subjected to immunoprecipitation with either an anti-WIP1 or an insulin 
receptor (IR) antibody (negative control), followed by Western Blot analysis with anti-
CDC5L. 
(B) Western Blot analysis of immunoreactive CDC5L in nuclear, cytosolic, and whole cell 
extracts (WCE) of control (WT) and PLRG-1-deficient (KO) MEFs. Representative results 
confirmed from three independent experiments. Anti-β-actin and anti-lamin A/C were used to 
control for equal loading. 
A 
B 
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1flox/flox MEFs treated with HTNC (Fig. 3.26, Fig. 3.12). MEFs treated with p53 
siRNA showed a decreased p53 expression, but no apparent phenotype and 
changes in Bax and p21 expression (Fig. 3.26). Cells treated with PLRG-1 
along with p53 siRNA reversed the PLRG-1-deficient phenotype showing no 
apoptosis and restoring Bax and p21 expression levels to those found in cells 
either left untransfected or transfected with control siRNA (Fig. 3.26). 
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Figure 3.26: Rescue of 
the apoptotic PLRG-1 
phenotype by 
knockdown of p53 
Upper panel: 
Representative 
photomicrographs of 
TUNEL stained MEFs 
treated with the 
respective siRNAs. 
Lower panel: Percentage 
of TUNEL positive cells 
in MEFs treated with the 
respective siRNAs. 
Values represent mean 
+ SEM from three 
independent 
experiments (∗∗∗p < 
0.001). 
(B) Western Blot 
analysis of MEFs treated 
with the respective 
siRNAs. Anti-β-actin was 
used to control for equal 
loading. 
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 In collaboration with the group of Prof. Hammerschmidt (University of 
Heidelberg), the subject was addressed whether p53 regulation accounted also 
for the effect of PLRG-1 deficiency in vivo, using a morpholino-mediated 
knockdown of the PLRG-1 homolog in zebrafish (Danio rerio).  
Its deduced amino acid sequence (Genbank accession number NM_213440) 
shows 77.9% identity to that of mouse plrg-1, indicating that this is a true 
ortholog. Whole-mount in situ hybridization analysis revealed ubiquitous 
distribution of zebrafish plrg-1 transcripts during all investigated developmental 
stages, i.e. from one-cell through to larval stages, indicating that the gene 
product is both maternally and zygotically derived (see http://zfin.org, gene 
expression).  
Inactivation of zebrafish plrg-1 by Prof. Hammerschmidt´s group with an 
antisense morpholino-oligonucleotide (MO) targeting the plrg-1 translation 
initiation site led to dose-dependent severe and wide-spread apoptosis that was 
already apparent at early segmentation stages (12 h post-fertilization (hpf)).  
Morphologically, the phenotype of MO-injected embryos was slightly 
stronger than that of naturally occurring zebrafish plrg-1 mutants (Amsterdam 
2004) see http://zfin.org, mutants). This indicated that in mutants, defects are 
partly rescued by maternally supplied plrg-1 transcripts, which in this model are 
inactivated by MO injection. However, MO treatment did not affect maternally 
derived PLRG-1 protein, which would explain why the defects of zebrafish 
morphants develop later than those of PLRG-1-deficient mice. Importantly, 
concomitant inactivation of zebrafish p53 in plrg-1 morphants via co-injection of 
plrg-1 and p53 MOs (Langheinrich et al., 2002) led to a significant attenuation of 
apoptosis and morphological defects, adding further in vivo evidence that 
apoptosis resulting from plrg-1 deficiency is p53-dependent. 
 The data described above demonstrate that by deleting PLRG-1 along 
with p53 it is possible to rescue the apoptotic phenotype of PLRG-1 deficiency 
in MEFs. The knockdown of both proteins enables the cells to survive and 
normalizes Bax and p21 expression to wild type levels.  
Taken together, it could be demonstrated that mouse PLRG-1 serves as 
an important nuclear regulator of complex formation between CDC5L and the 
p53 phosphatase WIP1, and thus is implicated in the control of G1/S-phase 
progression and apoptosis, thereby providing new insight into a novel 
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mechanism by which components of the spliceosome regulate cell cycle 
progression and apoptosis. Moreover, rescue of the PLRG-1-deficient 
phenotype in MEFs clearly establishes the causal role of p53 stabilization in the 
observed effects, further supporting the crucial role of the CDC5L-PLRG1 
spliceosome complex for nuclear targeting of p53 phosphatase complexes. 
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4 Discussion 
 
 
4.1 Essential role for PLRG-1 in the development of the preimplantation 
murine embryo 
 
The results obtained in this thesis reveal a crucial role for PLRG-1 in the 
development of the preimplantation murine embryo. In fact, the loss of PLRG-1 
constitutes such a severe impairment to the murine embryo that it leads to its 
death as early as embryonic day 1.5, a rarely described phenomenon in 
knockout mice. Apparently maternal PLRG-1 protein from the oocyte cannot 
compensate for the lack of PLRG-1 as early as the first day of embryogenesis, 
indicating a short half-life of PLRG-1 mRNA and protein. This notion is 
consistent with the fact that the amount of immunodetectable PLRG-1 in PLRG-
1flox/flox MEFs is already largely reduced after overnight incubation with cell-
permeable Cre . This finding is specific for mammals, because although 
inactivation of zebrafish plrg-1 with antisense morpholino-oligonucleotides (MO) 
also leads to wide-spread apoptosis, defects of zebrafish morphants develop 
later than those of PLRG-1-deficient mice (unpublished data, Hammerschmidt 
et al.). 
The mechanism, by which deletion of PLRG-1 ultimately results in 
embryonic lethality, is based on a failure in cell cycle progression. In yeast, the 
mutation of the PLRG-1 homologue YPL151c (Prp46) arrests cell proliferation 
causing a dual block in G/S- and M-phase progression (Albers et al., 2003; 
Sonnichsen et al., 2005). PLRG-1-deficient MEFs display a cell cycle arrest in 
G1/S phase and show an enlarged cell size. An increased cell size is typical for 
cells with a block in G1/S or G2/M transition due to cellular growth during gap 
phases (La Porta et al., 1998; Gandarillas et al., 2000). Enhanced stabilization 
of p53 ultimately leads to apoptosis of PLRG-1-deficient MEFs. Coinciding with 
the findings in vitro, analyses of a heart and a neuron-specific PLRG-1-deficient 
mouse strain display a similar severe apoptotic phenotype.  
Taken together, the results gathered from experiments using PLRG-1-
deficient MEFs and tissue-specific PLRG-1-deficient mouse models underline 
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the essential role of PLRG-1 in the regulation of cell proliferation and apoptosis 
independent from its postulated function in the regulation of pre-mRNA splicing.  
 
 
4.2 Disruption of other splicing factors and their effects 
 
To this date, only few knockout mice for components of the spliceosome 
have been described. Disruption of the splicing factor SRp20 was shown to 
result in early embryonic lethality. However, in contrast to PLRG-1-deficient 
embryos, SRp20-deficient embryos are still detectable at ED 3.5, despite the 
fact that immunoreactive SRp20 was already absent at the eight-cell stage 
(Jumaa et al., 1999). These data indicate that interference with splicing per se 
results in less dramatic effects on embryogenesis than disruption of PLRG-1. 
Similarly, disruption of the hnRNP C gene, encoding an essential component of 
hnRNP complexes involved in the regulation of pre-mRNA processing and 
export, results in embryonic lethality at ED 6.5 (Choi et al., 1986; Neubauer et 
al., 1998; Weighardt et al., 1996; Williamson et al., 2000). These previously 
described findings argue strongly for a specific additional or alternative role of 
PLRG-1 in cell cycle control and apoptosis rather than a general involvement in 
pre-mRNA processing and splicing.  
This was confirmed by quantitative Realtime PCR using exon-spanning 
primers, which, surprisingly, excluded aberrant splicing in PLRG-1-deficient 
MEFs. This stands in contrast to a previously published role for PLRG-1 in 
splicing reactions (Ajuh et al., 2001; Ajuh and Lamond, 2003). However, all 
published splicing defects in mammals caused by PLRG-1 deficiency were 
postulated using an adeno-pre-mRNA-vector, an artificial splicing assay system. 
In contrast, the data obtained indicates no or merely a redundant role for PLRG-
1 in splicing, showing that the functional role for PLRG-1 in mammals has 
diversified. In addition, the abberrant splicing for the TUB1 α-tubulin gene 
caused by the CDC5L mutation, the interaction partner of PLRG-1, did not 
occur in PLRG-1-deficient MEFs (Burns et al., 2002). PLRG-1-deleted cells 
showed an even higher expression of α-tubulin, which is consistent with the 
enlarged cell size. 
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 The in vitro studies on PLRG-1 interaction partners demonstrate that 
mouse PLRG-1 serves as an important nuclear regulator of complex formation 
between CDC5L and the p53 phosphatase WIP1, and thus is implicated in the 
control of G1/S phase progression. This provides the first insight into a novel 
mechanism by which components of the spliceosome regulate cell cycle 
progression and apoptosis (Fig. 4.2). The results also highlight the possibility 
that mammalian and human PLRG-1 orthologues function analogously in this 
pathway, whereas their duplicated plant orthologues have probably diverged 
functionally throughout evolution. 
 
 
4.3 Function of PLRG-1 orthologues  
 
In contrast to eukaryotic species, which only have one PLRG-1 
orthologue, Arabidopsis and other plants employ two PLRG-1 orthologues 
(Nemeth et al., 1998). Arabidopsis PRL1 and PRL2 exhibit a high degree of 
conservation in the C-terminal WD40 repeat domain, whereas their N-terminal 
sequences differ significantly (Nemeth et al., 1998). PRL1 has been initially 
identified as a transcriptional repressor in the regulation of glucose, sucrose and 
some plant hormone signaling pathways (Nemeth et al., 1998). Subsequent 
experiments showed that PRL1 interacts via its N-terminus with the α-subunits 
of Arabidopsis AMP-activated kinase orthologues AKIN10 and AKIN11 and 
inhibits the activity of these kinases in vitro (Bhalerao et al., 1999). The fact that 
no viable prl2 mutant could be isolated so far, suggests that PRL1 and PRL2 
perform only partly overlapping functions and that, similarly to mouse PLRG-1, 
homozygous Arabidopsis PRL2 mutants are not viable (Csaba Koncz, 
unpublished). Given the fact that yeast and mammalian orthologues (Prp46p 
and PLRG-1) of Arabidopsis PRL proteins play a critical role in pre-mRNA 
splicing and that mouse and human PLRG-1 does not interact with AMPKs 
(Andrea Mesaros, unpublished), it is possible that plant members of the 
Pleiotropic Regulator WD40 domain family play somewhat divergent roles in 
signaling compared to other members of this family. This is consistent with the 
findings, that splicing is unaltered in PLRG-1-deficient MEFs. 
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 In yeast, it has been demonstrated that the PLRG-1 orthologue Prp46p is 
essential for pre-mRNA splicing (Albers et al., 2003). Moreover, prp46 mutants 
exhibit a defect in cell cycle progression. While PLRG-1 deficiency in mouse 
leads to an arrest in G1/S phase transition (Fig. 3.11 and 12 in results), 
inactivation of yeast Prp46p results in impaired mitosis with a G2/M block 
(Albers et al., 2003). Biochemical and genetic studies demonstrate that Prp46p 
interacts with other components of the spliceosome, such as Prp45p, Prp19 
(Pso4) and Cef1p/Cdc5p (Ohi and Gould, 2002). Mutations of these 
spliceosomal components results in pleiotropic defects, including temperature 
sensitivity, enhanced sensitivity to mutagens and radiation and accumulation of 
pre-mRNA (Ohi and Gould, 2002). Although the molecular mechanisms 
resulting in cell cycle defects as a consequence of deletion of spliceosomal 
components have not been fully characterized, previous experiments in yeast 
demonstrate that defective pre-mRNA splicing directly blocks mitosis. Thus, 
altered splicing of a single intron from TUB1 α-tubulin gene, caused by the 
CDC5 mutation, results in the G2/M cell cycle defect in fission yeast (Burns et 
al., 2002). These data indicate that splicing of a critical component in cell cycle 
regulation may account for the defect present in mutants of yeast spliceosomal 
components. Nevertheless, deficiency for Prp17, another splicing factor, results 
in defects both in G1/S and G2/M progression, only the latter of which can be 
partially rescued by introducing an intronless tubulin gene (Chawla et al., 2003), 
indicating the presence of multiple pathways by which spliceosomal 
components can regulate cell cycle progression. 
 
 
4.4 PLRG-1 in control of cell cycle and apoptosis 
 
PLRG-1-deficient MEFs displayed a G1/S-phase block, resulting in 
decreased Cyclin D1 and Cyclin E expression and enhanced phosphorylated 
and thus stabilized p53 and increased p21 expression. Cyclin D1 expression is 
already reduced before serum stimulation, followed by a reduction in Cyclin E 
expression 6 h after serum stimulation of PLRG-1-deficient MEFs. This is 
consistent with findings that activated Cyclin D1/CDK4 complex 
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hyperphosphorylates Rb enabling E2F to act as a transcription factor (Schulze 
et al., 1994), which subsequently activates transcription of Cyclin E, forcing the 
progression into S-phase (Fig. 4.1). 
 
 
 
 
 
 
The diminished expression of Cyclin D1 was not due to a general 
alteration in pre-mRNA splicing, as seen in Fig. 3.13, but rather as a result from 
enhanced p53 stabilization. As published by Guardavaccaro and colleagues, 
the p53-inducible gene PC3 induces the accumulation of hypophosphorylated 
Rb, thereby leading to an arrest in G1-phase. In addition, PC3 inhibits Cyclin D1 
transcription, thus further contributing to the G1 arrest (Guardavaccaro et al., 
2000). The findings of unaltered general pre-mRNA splicing were contradictory 
to data published by Ajuh et al., who postulated a role for PLRG-1 in pre-mRNA 
Figure 4.1: Schematic representation of G1/S-phase progression and block  
Signaltransduction for G1/S-phase progression are depicted by black arrows. p53 
induction and block in progression are highlighted by red arrows. P represent 
phosphogroups 
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splicing in mammals (Ajuh et al., 2001; Ajuh and Lamond, 2003). As mentioned 
earlier, pre-mRNA splicing was investigated using an adeno-pre-mRNA-vector, 
a confirmed, yet artificial system.  
Up to now, pre-mRNA splicing and expression of endogenous genes had 
not been studies in vivo. These data obtained is contradictory to published 
findings in yeast showing the importance for Prp46p (PLRG-1) in pre-mRNA 
splicing (Albers et al., 2003). Deletion of CDC5L in yeast leads to a G2/M block 
and the phenotype was rescued by introducing intronless α-tubulin cDNA into 
Saccharomyces cerevisiae, showing that removal of a single α-tubulin gene 
intron suppresses the cell cycle arrest phenotype (Burns et al., 2002). PLRG-1-
deficient MEFs exhibit a 1.5fold increase in α-tubulin expression, indicating that 
PLRG-1 deficiency does not impair its expression. The enhanced expression of 
α-tubulin is consistent with the observation of the enlarged cell size of PLRG-1-
deficient MEFs, indicating an enlarged cytoskeleton. The appearance of the 
knockout cells resembles the phenotype of senescent cells, which are 
characterized by enlargement and flattening of the cell (Bayreuther et al., 1992).  
In terms of apoptosis, PLRG-1 deficiency resulted in enhanced p53 
phosphorylation and stabilization, leading to a cell cycle block and apoptosis. 
This is consistent with findings, where wild type MEFs were irradiated with UV 
as an exogenous damage reagent. UV treatment led to enhanced p53 
phosphorylation promoting p21 expression and to a decline in Bcl-2, resulting in 
apoptosis (Tomicic et al., 2005). PLRG-1-deficient MEFs and PLRG-1∆mus mice 
showed increased Bax levels, due to p53 stabilization, whereas PLRG-1∆CNS 
mice exhibited no difference in Bax expression compared to controls. Miyashita 
et al. showed that the tumour suppressor p53 is a direct transcriptional activator 
of the human Bax gene, further confirming the enhanced Bax expression 
observed in cell culture experiments and investigation of PLRG-1∆mus mice 
(Miyashita et al., 1995). However, Morris et al. could show p53-mediated Bax 
activation in neurons after DNA damage by translocation of Bax from the 
cytoplasm to the mitochondria and not by enhanced expression (Morris et al., 
2001). Wang et al., showed a similar phenotype in terms of apoptosis in heart 
by knockdown of Tfam using the MCK-Cre mouse strain. The mice died 2-4 
weeks after birth due to respiratory chain deficiency, dilated cardiomyopathy 
and atrioventricular heart conduction blocks (Wang et al., 1999). Contrary to our 
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findings that no deletion of PLRG-1 occurred in skeletal muscle using the MCK-
Cre strain, they confirmed deletion of Tfam in this tissue. However, deletion of 
Tfam was investigated at day 32, a time point at which all PLRG-1∆mus mice had 
already died. This indicates that MCK-Cre is potentially active from day 10 on, 
when considering the existence of PLRG-1 in skeletal muscle in the first days 
after birth.  
The early postnatal death of the PLRG-1 ∆CNS mice was a result of 
enhanced apoptosis in the dentate gyrus. Kim et al., showed that apoptosis in 
the dentate gyrus occurred in anorexia mice. These mice died during the third 
or fourth postnatal week, a similar strong phenotype as observed in PLRG-1 
∆CNS mice. In addition, these mice displayed neurological defects, such as body 
tremors, a feature monitored in PLRG-1 ∆CNS mice (Kim et al., 2001). 
 Taken together, these data indicate the importance of PLRG-1 in mitotic 
cells. 
 
 
4.5 Impaired DNA damage repair as a consequence of PLRG-1 deficiency 
 
PLRG-1-deficient MEFs exhibit no spontaneously detectable DNA 
double-strand breaks, but showed impaired DNA damage repair after UV 
treatment, indicating that PLRG-1 deficiency results in UV hypersensitivity. 
Mutation of ERCC1, a protein involved in nucleotide exchange repair, also 
results in UV hypersensitivity, supplying a possible connection to the DNA 
damage repair pathway (Johansson et al., 2004; Melton et al., 1998).  
The enhanced appearance of γ-H2AX foci in PLRG-1-deficient MEFs 
indicates that these cells are sensitive to stalled replication forks without the 
ability to repair these. It was shown that pulse-field gel electrophoresis as a 
method for detection of DNA double-strand breaks reveals a sensitivity in 
detection of DNA double-strand breaks of a minimum of 100 lesions per cell 
(Johansson et al., 2004). The appeareance of more than 100 γ-H2AX foci per 
cell (PLRG-1-deficient nuclei exhibit a complete accumulation of the foci), 
without detectable DNA double-strand breaks via pulse-field gel electrophoresis 
indicates that DNA lesions rather represent stalled replication forks than DNA 
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double-strand breaks. These findings were unexpected, because of previous 
data obtained that cells are arrested in the G1-phase prior to the start of DNA 
replication in the S-phase. Possibly, when PLRG-1 is deleted in MEFs currently 
in the beginning of the S-phase, stalled replication forks occur leading to the 
observed phenotype. In addition, FACS analysis showed that the percentage of 
cells in S-phase was raised from 2.3 to 3.2% in PLRG-1-deficient MEFs 
indicating that these cells either do not show a complete deletion of PLRG-1 or 
a small proportion of cells enter the S-phase and directly stop progressing 
throughout the cell cycle due to spontaneously occurring DNA lesions. 
Replication forks, bulky DNA lesions or interstrand crosslinks are often 
spontaneously generated. Bulky DNA lesions are constantly produced by 
endogenously generated oxidative damage in mammalian cells (Melton et al., 
2004). Furthermore, metabolic byproducts, such as malonyldialdehyde, cause 
interstrand crosslinks (Chaudhary et al., 1994) and DNA secondary structures, 
such as hairpins or G4-tetraplex structure at telomeres, cause stalled replication 
forks (Cromie et al., 2000; Samadashwily et al., 1997). Hence, naturally 
occuring stalled replication forks are common in mammalian cells and result in 
γ-H2AX foci, also observed in untreated PLRG-1flox/flox MEFs. The increase in γ-
H2AX foci in PLRG-1-deficient MEFs seems to occur from such lesions, 
because these cells did not exhibit enhanced DNA double-strand breaks. When 
encountering interstrand crosslinks, the cell uses the NER pathway followed by 
homologous recombination to repair this DNA damage (Niedernhofer et al., 
2004). Because PLRG-1-deficient cells cannot progress in cell cycle, it seems 
impossible for these cells to repair these lesions. 
ATR, a member of the PIKK-family, controls the integrity of DNA 
replication in unstressed cells (Shechter et al., 2004, Shechter et al., 2004). 
Thus, future experiments will have to address the role of ATR in mediating the 
PLRG-1-deficient phenotype. 
The appearance of PLRG-1-deficient MEFs resembles that of senescent 
cells, displaying larger cell size and a flattened cell shape (Bayreuther et al., 
1992). Another senescent-specific feature is an increase in telomere-
dysfunction-induced foci, resulting in enhanced recruitment of γ-H2AX and other 
DNA damage response factors to telomeres (Takai et al., 2003). Herbig et al. 
could show that telomere shortening triggers senescence of human cells 
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through a pathway involving p53 and p21, an upregulation of proteins also 
observed in PLRG-1-deficient MEFs, and resulting in a G1 arrest (Herbig et al., 
2004). However, deletion of PLRG-1 in MEFs showed this senescence-like 
phenotype for a maximum of 4-7 days due to p53-induced apoptosis. Whether 
PLRG-1 deficiency has an effect on senescent cells, despite their inability to 
divide and the accumulation of DNA double-strand breaks (Sedelnikova et al., 
2004), remains unknown.  
It remains elusive, whether PLRG-1 is recruited to DNA lesions with the 
Pso4-complex. Further investigation will show, if ATM or ATR plays the 
important role in phosphorylating p53 at serine 15 in this context.  
 
 
4.6 Proposed model for PLRG-1, linking DNA repair, control of cell cycle 
progression and apoptosis via the Pso4-complex 
 
 This thesis demonstrated that murine PLRG-1 serves as an important 
regulator of complex formation between CDC5L and the p53 phosphatase WIP1 
and is implicated in the control of G1/S-phase progression and apoptosis; 
thereby, providing new insight into a novel mechanism by which members of the 
Pso4-complex are involved in the regulation of cell cycle progression, DNA 
damage repair and apoptosis (Fig. 4.2). This cell cycle defect is accompanied 
by increased p53 phosphorylation and expression, which results from failure of 
CDC5L to interact with the p53 phosphatase WIP1 in PLRG-1-deficient cells. 
Unlike the PLRG-1 mutants, WIP1-deficient mice are viable to adulthood, 
indicating that additional p53 phosphatases are associated with CDC5L (Anton 
et al., 2002). Thus, in addition to WIP1, PP-1 phosphatase was also detected in 
CDC5L-associated protein complexes by mass spectrometry. Furthermore, 
active PP1 co-purifies with CDC5L and CDC5L directly interacts with the PP1-
binding nuclear-scaffold protein NIPP1 (Boudrez et al., 2000). Interestingly, 
disruption of the NIPP1 gene also results in early embryonic lethality although at 
a later stage (ED 6.5) (Van Eynde et al., 2004). Therefore, it is proposed that 
CDC5L interacts with multiple p53 phosphatases including WIP1 and PP-1α 
and that cytosolic relocation of CDC5L as a consequence of PLRG-1 deficiency 
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has a more severe effect than individual deletion or inhibition of these 
phosphatases. Moreover, rescue of the PLRG-1-deficient phenotype in both 
MEFs and zebrafish in vivo clearly establishes the causal role of p53 
stabilization in the observed effects, thereby further supporting the crucial role 
of the CDC5L-PLRG-1 spliceosome complex for nuclear targeting of p53 
phosphatase complexes. 
 The WRN/Pso4-CDC5L-PLRG-1 complex interaction is essential for 
uncoupling of DNA interstrand crosslinks (Zhang et al., 2005). The findings, that 
PLRG-1 deficiency results in enhanced appearance of γ-H2AX foci and 
impaired DNA damage repair, lead to the assumption that PLRG-1 is crucial for 
stabilizing the multiprotein-complex implicated in DNA damage repair. 
Therefore, these data extend the role of the Pso4-CDC5L-PLRG-1 complex 
beyond the regulation of pre-mRNA splicing to DNA repair (Zhang et al., 2005). 
Thus, direct integration of interstrand crosslink uncoupling in the regulation of 
p53 stability through Pso4-CDC5L-PLRG-1-regulated phosphorylation provides 
a new working model (Fig. 4.2). Namely, cell cycle arrest initiated upon stalled 
replication forks or double-strand break could be resolved by the final steps of 
interstrand crosslink uncoupling to signal successful repair to the cell and allow 
further cell cycle progression. In this model, DNA double-strand breaks as 
intermediates of interstrand crosslink (ICL) repair result in the activation of the 
ATM kinase family, stimulating p53 phosphorylation and stabilization. This 
subsequently leads to increased Cdk-inhibitor p21 expression and ultimately to 
stimulation of expression of the pro-apoptotic Bax protein. If ICL repair proceeds 
successfully, the Pso4-CDC5L-PLRG-1 complex recruited to the ICL site, 
promoting interaction of CDC5L with the p53 phosphatase, allows for 
dephosphorylation and subsequent degradation of p53. This stimulates re-entry 
into the cell cycle and inhibits apoptosis (Fig. 4.2).  
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 Although in the present experiments, the role of Pso4-CDC5L-PLRG-1-
mediated p53 regulation in ICL repair was not directly investigated, further 
studies are in progress to clarify the role of Pso4-CDC5L-PLRG-1-mediated p53 
regulation in ICL repair. 
 This novel link between spliceosomal and DNA-repair components and 
the regulation of cell cycle progression and apoptosis appears particularly 
interesting as in many mammalian tumors CDC5L and/or PLRG-1 are 
overexpressed (Fenske et al., 2006; Geigl et al., 2004; Groenen et al., 1998). 
Hence, the interaction of overexpressed CDC5L with p53 phosphatases may 
provide a new mechanism for p53 suppression in tumorigenesis. Further 
characterization of the signaling network including additional partners of PLRG-
Figure 4.2: Proposed model for novel integration of pre-mRNA splicing components 
linking DNA repair, and control of cell cycle progression and apoptosis via CDC5L-
PLRG-1 interaction 
The Pso4-CDC5L-PLRG-1 complex in cooperation with the Werner protein (WRN) helicase 
and RPA (not shown) regulates DNA interstrand crosslinks and is thus required for DNA 
repair. The CDC5L-PLRG-1 complex was also identified as a critical component of the 
spliceosome and the interaction of both proteins was demonstrated to be crucial for pre-
mRNA splicing. The data presented here reveal that the same CDC5L-PLRG-1 complex 
interacts with p53 phosphatases and that lack of PLRG-1 disrupts the interaction of these 
phosphatases with CDC5L, thus resulting in p53 phosphorylation and stabilization leading to 
induction of G1/S arrest and apoptosis. 
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1, CDC5L, and the p53 phosphatase WIP1 is therefore expected to help in 
further deciphering regulatory links between common components of splicing 
and DNA repair pathways and may yet uncover functions in malignant 
transformation. 
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5 Summary 
 
 
 Mammalian Pleiotropic Regulator PLRG-1 was initially identified as a 
component of the spliceosome and belongs to a highly conserved family of 
seven WD40 domain containing proteins in eukaryotes (Ajuh et al., 2000; Ajuh 
et al., 2001). Founding members of this WD40-repeat protein family, PRL1 and 
PRL2, were first identified by T-DNA tagging in Arabidopsis thaliana (Nemeth et 
al., 1998). Whereas in plants the PRL genes are uniquely duplicated, in yeast, 
C. elegans and mammals there are only single orthologues of the Pleiotropic 
Regulator family which play important roles in the control of cellular 
homeostasis by forming at least in mammals, a complex with Pso4 and the cell 
division and cycle 5 homolog (CDC5L), that regulates both pre-mRNA splicing 
and DNA repair.  
 To characterize the role of PLRG-1 in vivo, in the present study, I 
inactivated its gene both conventionally and conditionally in mice. Here, it is 
shown that inactivation of PLRG-1 results in embryonic lethality 1.5 days post-
fertilization in mice, indicating a fundamental role for PLRG-1 in early cell cycle 
events. Studies on heart- and neuron-specific PLRG-1 knockout mice revealed 
that massive apoptosis was responsible for their premature death. Moreover, 
PLRG-1-deficient mouse embryonic fibroblasts (MEFs) fail to enter S-phase 
upon serum stimulation and show increased apoptosis resulting from enhanced 
p53 phosphorylation and stabilization. Interestingly, p53-phosphatase WIP1 
was seen to interact with CDC5L in wild-type, but not in PLRG-1-deficient MEFs 
due to cytosolic translocation of CDC5L. p53 downregulation rescues lethality in 
PLRG-1-deficient MEFs, showing that apoptosis resulting from PLRG-1-
deficiency is p53 dependent Taken together, it is shown that the Pso4-CDC5L-
PLRG-1 complex controls cell proliferation and apoptosis by novel integration of 
pre-mRNA splicing and DNA repair via a p53-phosphorylation-dependent 
pathway, thus providing the first evidence for Pso4-complex regulation of p53. 
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 PLRG-1 gehört zu einer hoch konservierten Proteinfamilie in Eukaryoten, 
welche sich durch wiederholende WD40 Dömanen auszeichnet und wurde in 
Säugern als Bestandteil des Spliceosoms identifiziert (Ajuh et al., 2000; Ajuh et 
al., 2001). Die ersten Mitglieder dieser Familie ,PRL1 und PRL2, wurden durch 
T-DNA Markierung in Arabidopsis thaliana gefunden (Nemeth et al., 1998). 
Während in Pflanzen die PRL Gene dupliziert sind, gibt es in Hefe, C.elegans 
und Säugern jeweils nur ein Ortholog der pleiotropen Regulatorfamilie, welche 
ein wichtige Rolle in der Kontrolle der Zellhomöostase innehaben. Zumindest in 
Säugern formt PLRG-1 einen Komplex mit Pso4 und dem cell division and cycle 
5 homolog (CDC5L), welcher sowohl an der Regulation des pre-mRNA 
Spleißens und auch an der DNA Reparatur beteiligt ist. 
 Um die Funktion von PLRG-1 in Säugern in vivo zu charakterisieren, 
habe ich im Rahmen der vorliegenden Arbeit des PLRG-1-Gen in Mäusen 
sowohl konventionell, als auch konditionell inaktiviert. Es konnte gezeigt 
werden, dass die Inaktivierung von PLRG-1 in Mäusen embryonale Lethalität an 
Tag 1,5 nach Befruchtung der Eizelle zur Folge hat, welches für eine 
fundamentale Rolle von PLRG-1 in der ersten Zellteilung spricht. Herz- und 
Neuron-spezifischen Knockout Mäuse weisen eine massive Apoptose in diesen 
Organen auf, welche zu deren frühzeitigem Tod führt. Außerdem verlieren 
PLRG-1-defiziente Mausembryofibroblasten (MEFs) die Fähigkeit, nach 
Serumstimulation in die S-Phase einzutreten und weisen eine erhöhte Apoptose 
auf, welche aus vermehrter p53 Phosphorylierung und Stabilisierung resultiert. 
Interessanterweise interagiert die p53-Phosphatase WIP1 mit CDC5L in 
Wildtypenzellen, nicht jedoch, aufgrund der cytosolischen Translokation von 
CDC5L, in PLRG-1-defizienten MEFs. Die Herunterregulierung von p53 rettet 
die Lethalität sowohl in PLRG-1 defizienten MEFs als auch in Zebrafisch in vivo, 
und verdeutlicht, dass die durch PLRG-1 Defizienz hervorgerufene Apoptose 
p53 abhängig ist. Zusammenfassend konnte gezeigt werden, dass der Pso4-
CDC5L-PLRG-1 Komplex Zellproliferation und Apoptose, durch p53-Regulation 
kontrolliert. 
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In dieser Arbeit wurde die Rolle von PLRG-1 in vitro und in vivo 
untersucht. Die Erzeugung und Untersuchung von PLRG-1-defizienten 
Mausembryofibroblasten und Mäusen ergab, dass die Inaktivierung von PLRG-
1 in Säugern einen G1/S Zellzyklusarrest und massive Apoptose induziert. Der 
Zellzyklusarrest, sowie die Apoptose resultieren aus einer Stabilisierung des 
p53 Proteins, sowie des Fehlens der Interaktion der p53 Phosphatase WIP1 mit 
CDC5L. Die Herunterregulierung von p53 rettet die Lethalität PLRG-1-
defizienter Zellen und verdeutlicht, dass die Apoptose, hervorgerufen durch 
PLRG-1 Defizienz, p53 abhängig ist. Es konnte gezeigt werden, dass der Pso4-
CDC5L-PLRG-1 Komplex Zellproliferation und Apoptose, durch eine neue 
Integration von DNA Reparatur über einen p53-Phosphorylierung-abhängigen 
Signalweges kontrolliert. 
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